International Clinical Trials in Musculoskeletal

Albania

• Post-Menopausal Osteoporosis: BONCURE Study: A Study of Monthly Bonviva (Ibandronate) in Women With Post-Menopausal Osteoporosis on Bisphosphonate Therapy.
  Tirana; Research Site:
  
  

Argentina

• Lupus: A Study of CellCept (Mycophenolate Mofetil) in Management of Patients With Lupus Nephritis.
  Buenos Aires ; Research Site:
  
  
• Lupus: A Study of CellCept (Mycophenolate Mofetil) in Management of Patients With Lupus Nephritis.
  Ciudad Autónoma De Bs. As.; Research Site:
  
  
• Lupus: A Study of CellCept (Mycophenolate Mofetil) in Management of Patients With Lupus Nephritis.
  Córdoba; Research Site:
  
  
• Lupus: A Study of CellCept (Mycophenolate Mofetil) in Management of Patients With Lupus Nephritis.
  Florida; Research Site:
  
  
• Lupus: A Study of CellCept (Mycophenolate Mofetil) in Management of Patients With Lupus Nephritis.
  Tucuman; Research Site:
  
  
• Post-Menopausal Osteoporosis: A Study of Bonviva (Ibandronate) and Alendronate on Renal Function in Postmenopausal Women With Osteoporosis at High Risk for Renal Disease.
  Buenos Aires ; Research Site:
  
  
• Post-Menopausal Osteoporosis: A Study of Bonviva (Ibandronate) and Alendronate on Renal Function in Postmenopausal Women With Osteoporosis at High Risk for Renal Disease.
  Cordoba; Research Site:
  
  
• Post-Menopausal Osteoporosis: A Study of Bonviva (Ibandronate) and Alendronate on Renal Function in Postmenopausal Women With Osteoporosis at High Risk for Renal Disease.
  Santa Fe; Research Site:
  
  
• Post-Menopausal Osteoporosis: A Study of Bonviva (Ibandronate) in Women With Post-Menopausal Osteoporosis
  Buenos Aires ; Research Site:
  
  
• Rheumatoid Arthritis: A Non-Comparative Study to Assess the Safety of MabThera (Rituximab) in Patients With Rheumatoid Arthritis.
  Buenos Aires ; Research Site:
  
  
• Rheumatoid Arthritis: A Non-Comparative Study to Assess the Safety of MabThera (Rituximab) in Patients With Rheumatoid Arthritis.
  Córdoba; Research Site:
  
  
• Rheumatoid Arthritis: A Non-Comparative Study to Assess the Safety of MabThera (Rituximab) in Patients With Rheumatoid Arthritis.
  Tucuman; Research Site:
  
  
• Rheumatoid Arthritis: A Study of Ocrelizumab Given as a Single or Dual Infusion in Patients With Rheumatoid Arthritis Who Have an Inadequate Response to Methotrexate
  Buenos Aires ; Research Site:
  
  
• Rheumatoid Arthritis: A Study of Ocrelizumab Given as a Single or Dual Infusion in Patients With Rheumatoid Arthritis Who Have an Inadequate Response to Methotrexate
  Tucuman; Research Site:
  
  
• Rheumatoid Arthritis: A Study of Ocrelizumab in Combination With Methotrexate in Patients With Rheumatoid Arthritis Who Are Naive to Methotrexate
  Buenos Aires ; Research Site:
  
  
• Rheumatoid Arthritis: A Study of Ocrelizumab in Combination With Methotrexate in Patients With Rheumatoid Arthritis Who Are Naive to Methotrexate
  Rosario; Research Site:
  
  
• Rheumatoid Arthritis: A Study of Ocrelizumab in Patients With Rheumatoid Arthritis Who Have an Inadequate Response to anti-TNF-alpha Therapy.
  Buenos Aires ; Research Site:
  
  
• Rheumatoid Arthritis: A Study of Ocrelizumab in Patients With Rheumatoid Arthritis Who Have an Inadequate Response to anti-TNF-alpha Therapy.
  San Juan; Research Site:
  
  
• Rheumatoid Arthritis: A Study of Ocrelizumab in Patients With Rheumatoid Arthritis Who Have an Inadequate Response to anti-TNF-alpha Therapy.
  Tucuman; Research Site:
  
  
• Rheumatoid Arthritis: A Study of Ocrelizumab in Patients With Rheumatoid Arthritis Who Have an Inadequate Response to Methotrexate.
  Buenos Aires ; Research Site:
  
  
• Rheumatoid Arthritis: A Study of Ocrelizumab in Patients With Rheumatoid Arthritis Who Have an Inadequate Response to Methotrexate.
  Rosario; Research Site:
  
  
• Rheumatoid Arthritis: A Study of Tocilizumab in Patients Completing Treatment in WA17822
  Buenos Aires ; Research Site:
  
  
• Rheumatoid Arthritis: A Study to Assess the Effect of Tocilizumab + DMARD Therapy on Signs and Symptoms in Patients With Moderate to Severe Active Rheumatoid Arthritis
  Buenos Aires ; Research Site:
  
  
• Rheumatoid Arthritis: A Study to Assess the Effect of Tocilizumab + DMARD Therapy on Signs and Symptoms in Patients With Moderate to Severe Active Rheumatoid Arthritis
  Rosario; Research Site:
  
  
• Rheumatoid Arthritis: A Study to Assess the Effect of Tocilizumab + Methotrexate on Signs and Symptoms in Patients With Moderate to Severe Active Rheumatoid Arthritis
  Buenos Aires ; Research Site:
  
  
• Rheumatoid Arthritis: A Study to Assess the Safety and Efficacy of Tocilizumab in Patients With Active Rheumatoid Arthritis
  Buenos Aires ; Research Site:
  
  
• Rheumatoid Arthritis: A Study to Assess the Safety and Efficacy of Tocilizumab in Patients With Active Rheumatoid Arthritis
  Rosario; Research Site:
  
  
• Rheumatoid Arthritis: An Extension Study of Tocilizumab in Patients Completing Treatment in Tocilizumab Core Studies
  Buenos Aires ; Research Site:
  
  
• Rheumatoid Arthritis: An Extension Study of Tocilizumab in Patients Completing Treatment in Tocilizumab Core Studies
  Rosario; Research Site:
  
  
• Rheumatoid Arthritis: SCORE Study: A Study of MabThera (Rituximab) in Patients With Rheumatoid Arthritis and Inadequate Response to Methotrexate.
  Buenos Aires ; Research Site:
  
  
• Systemic Lupus Erythematosus: A Study of Ocrelizumab in Patients With Nephritis Due to Systemic Lupus Erythematosus.
  Buenos Aires ; Research Site:
  
  
• Systemic Lupus Erythematosus: A Study of Ocrelizumab in Patients With Nephritis Due to Systemic Lupus Erythematosus.
  Córdoba; Research Site:
  
  
• Systemic Lupus Erythematosus: A Study of Ocrelizumab in Patients With Nephritis Due to Systemic Lupus Erythematosus.
  San Juan; Research Site:
  
  
• Systemic Lupus Erythematosus: A Study of Ocrelizumab in Patients With Nephritis Due to Systemic Lupus Erythematosus.
  San Miguel De Tucuman; Research Site:
  
  
• Systemic Lupus Erythematosus: A Study of Ocrelizumab in Patients With Nephritis Due to Systemic Lupus Erythematosus.
  Tucuman; Research Site:
  
  
• Systemic Lupus Erythematosus: A Study of Ocrelizumab in Patients With Systemic Lupus Erythematosus.
  Buenos Aires ; Research Site:
  
  
• Systemic Lupus Erythematosus: A Study of Ocrelizumab in Patients With Systemic Lupus Erythematosus.
  Córdoba; Research Site:
  
  
• Systemic Lupus Erythematosus: A Study of Ocrelizumab in Patients With Systemic Lupus Erythematosus.
  San Juan; Research Site:
  
  
• Systemic Lupus Erythematosus: A Study of Ocrelizumab in Patients With Systemic Lupus Erythematosus.
  San Miguel De Tucuman; Research Site:
  
  
• Systemic Lupus Erythematosus: A Study of Ocrelizumab in Patients With Systemic Lupus Erythematosus.
  Tucuman; Research Site:
  
  

Australia

• Lupus: A Study of CellCept (Mycophenolate Mofetil) in Management of Patients With Lupus Nephritis.
  Melbourne; Research Site:
  
  
• Post-Menopausal Osteoporosis: A Study of Bonviva (Ibandronate) in Women With Post-Menopausal Osteoporosis Who Have Received Previous Bonviva Treatment
  St. Leonards; Research Site:
  
  
• Post-Menopausal Osteoporosis: A Study of Bonviva (Ibandronate) in Women With Post-Menopausal Osteoporosis Who Have Received Previous Bonviva Treatment
  Sydney; Research Site:
  
  
• Post-Menopausal Osteoporosis: DIVA Study - A Study of Different Regimens of Intravenous Administration of Bonviva (Ibandronate) in Women With Post-Menopausal Osteoporosis
  Darlinghurst; Research Site:
  
  
• Post-Menopausal Osteoporosis: DIVA Study - A Study of Different Regimens of Intravenous Administration of Bonviva (Ibandronate) in Women With Post-Menopausal Osteoporosis
  Melbourne; Research Site:
  
  
• Post-Menopausal Osteoporosis: DIVA Study - A Study of Different Regimens of Intravenous Administration of Bonviva (Ibandronate) in Women With Post-Menopausal Osteoporosis
  Nedlands; Research Site:
  
  
• Post-Menopausal Osteoporosis: DIVA Study - A Study of Different Regimens of Intravenous Administration of Bonviva (Ibandronate) in Women With Post-Menopausal Osteoporosis
  St. Leonards; Research Site:
  
  
• Post-Menopausal Osteoporosis: DIVA Study - A Study of Different Regimens of Intravenous Administration of Bonviva (Ibandronate) in Women With Post-Menopausal Osteoporosis
  Sydney; Research Site:
  
  
• Post-Menopausal Osteoporosis: MOBILE Study - A Study of Bonviva (Ibandronate) Regimens in Women With Post-Menopausal Osteoporosis
  Adelaide; Research Site:
  
  
• Post-Menopausal Osteoporosis: MOBILE Study - A Study of Bonviva (Ibandronate) Regimens in Women With Post-Menopausal Osteoporosis
  Parkville; Research Site:
  
  
• Post-Menopausal Osteoporosis: MOBILE Study - A Study of Bonviva (Ibandronate) Regimens in Women With Post-Menopausal Osteoporosis
  Perth; Research Site:
  
  
• Rheumatoid Arthritis: A Study of MabThera (Rituximab) in Combination With Methotrexate in Methotrexate-Naive Patients With Rheumatoid Arthritis (RA)
  Hobart; Research Site:
  
  
• Rheumatoid Arthritis: A Study of MabThera (Rituximab) in Combination With Methotrexate in Methotrexate-Naive Patients With Rheumatoid Arthritis (RA)
  Shenton Park; Research Site:
  
  
• Rheumatoid Arthritis: A Study of Ocrelizumab Given as a Single or Dual Infusion in Patients With Rheumatoid Arthritis Who Have an Inadequate Response to Methotrexate
  Campsie; Research Site:
  
  
• Rheumatoid Arthritis: A Study of Ocrelizumab Given as a Single or Dual Infusion in Patients With Rheumatoid Arthritis Who Have an Inadequate Response to Methotrexate
  Malvern; Research Site:
  
  
• Rheumatoid Arthritis: A Study of Ocrelizumab in Combination With Methotrexate in Patients With Rheumatoid Arthritis Who Are Naive to Methotrexate
  Malvern; Research Site:
  
  
• Rheumatoid Arthritis: A Study of Ocrelizumab in Combination With Methotrexate in Patients With Rheumatoid Arthritis Who Are Naive to Methotrexate
  Maroochydore; Research Site:
  
  
• Rheumatoid Arthritis: A Study of Ocrelizumab in Patients With Rheumatoid Arthritis Who Have an Inadequate Response to anti-TNF-alpha Therapy.
  Maroochydore; Research Site:
  
  
• Rheumatoid Arthritis: A Study of Ocrelizumab in Patients With Rheumatoid Arthritis Who Have an Inadequate Response to anti-TNF-alpha Therapy.
  Shenton Park; Research Site:
  
  
• Rheumatoid Arthritis: A Study of Ocrelizumab in Patients With Rheumatoid Arthritis Who Have an Inadequate Response to anti-TNF-alpha Therapy.
  Woolloongabba; Research Site:
  
  
• Rheumatoid Arthritis: A Study of Ocrelizumab in Patients With Rheumatoid Arthritis Who Have an Inadequate Response to Methotrexate.
  Maroochydore; Research Site:
  
  
• Rheumatoid Arthritis: A Study of Ocrelizumab in Patients With Rheumatoid Arthritis Who Have an Inadequate Response to Methotrexate.
  Shenton Park; Research Site:
  
  
• Rheumatoid Arthritis: A Study of Ocrelizumab in Patients With Rheumatoid Arthritis.
  Perth; Research Site:
  
  
• Rheumatoid Arthritis: A Study of P38 Inhibitor (4) in Patients With Active Rheumatoid Arthritis (RA) on Stable Methotrexate Therapy
  Caboolture; Research Site:
  
  
• Rheumatoid Arthritis: A Study of P38 Inhibitor (4) in Patients With Active Rheumatoid Arthritis (RA) on Stable Methotrexate Therapy
  Fitzroy; Research Site:
  
  
• Rheumatoid Arthritis: A Study of P38 Inhibitor (4) in Patients With Active Rheumatoid Arthritis (RA) on Stable Methotrexate Therapy
  Kipparing; Research Site:
  
  
• Rheumatoid Arthritis: A Study of Retreatment With MabThera (Rituximab) in Combination With Methotrexate in Patients With Rheumatoid Arthritis (RA)
  Coffs Harbour; Research Site:
  
  
• Rheumatoid Arthritis: A Study of Retreatment With MabThera (Rituximab) in Combination With Methotrexate in Patients With Rheumatoid Arthritis (RA)
  Maroochydore; Research Site:
  
  
• Rheumatoid Arthritis: A Study of Retreatment With MabThera (Rituximab) in Combination With Methotrexate in Patients With Rheumatoid Arthritis (RA)
  Melbourne; Research Site:
  
  
• Rheumatoid Arthritis: A Study of Retreatment With MabThera (Rituximab) in Combination With Methotrexate in Patients With Rheumatoid Arthritis (RA)
  Sydney; Research Site:
  
  
• Rheumatoid Arthritis: A Study of Tocilizumab in Patients Completing Treatment in WA17822
  Adelaide; Research Site:
  
  
• Rheumatoid Arthritis: A Study of Tocilizumab in Patients Completing Treatment in WA17822
  Maroochydore; Research Site:
  
  
• Rheumatoid Arthritis: A Study of Tocilizumab in Patients Completing Treatment in WA17822
  Shenton Park; Research Site:
  
  
• Rheumatoid Arthritis: A Study to Assess the Effect of Tocilizumab + DMARD Therapy on Signs and Symptoms in Patients With Moderate to Severe Active Rheumatoid Arthritis
  Sydney; Research Site:
  
  
• Rheumatoid Arthritis: A Study to Assess the Effect of Tocilizumab + Methotrexate on Prevention of Structural Joint Damage in Patients With Moderate to Severe Active Rheumatoid Arthritis
  Adelaide; Research Site:
  
  
• Rheumatoid Arthritis: A Study to Assess the Effect of Tocilizumab + Methotrexate on Prevention of Structural Joint Damage in Patients With Moderate to Severe Active Rheumatoid Arthritis
  Malvern; Research Site:
  
  
• Rheumatoid Arthritis: A Study to Assess the Effect of Tocilizumab + Methotrexate on Prevention of Structural Joint Damage in Patients With Moderate to Severe Active Rheumatoid Arthritis
  Melbourne; Research Site:
  
  
• Rheumatoid Arthritis: A Study to Assess the Effect of Tocilizumab + Methotrexate on Prevention of Structural Joint Damage in Patients With Moderate to Severe Active Rheumatoid Arthritis
  Newcastle; Research Site:
  
  
• Rheumatoid Arthritis: A Study to Assess the Effect of Tocilizumab + Methotrexate on Prevention of Structural Joint Damage in Patients With Moderate to Severe Active Rheumatoid Arthritis
  Shenton Park; Research Site:
  
  
• Rheumatoid Arthritis: A Study to Assess the Effect of Tocilizumab + Methotrexate on Prevention of Structural Joint Damage in Patients With Moderate to Severe Active Rheumatoid Arthritis
  St. Leonards; Research Site:
  
  
• Rheumatoid Arthritis: A Study to Assess the Effect of Tocilizumab + Methotrexate on Signs and Symptoms in Patients With Moderate to Severe Active Rheumatoid Arthritis
  Adelaide; Research Site:
  
  
• Rheumatoid Arthritis: A Study to Assess the Effect of Tocilizumab + Methotrexate on Signs and Symptoms in Patients With Moderate to Severe Active Rheumatoid Arthritis
  Maroochydore; Research Site:
  
  
• Rheumatoid Arthritis: A Study to Assess the Effect of Tocilizumab + Methotrexate on Signs and Symptoms in Patients With Moderate to Severe Active Rheumatoid Arthritis
  Shenton Park; Research Site:
  
  
• Rheumatoid Arthritis: A Study to Assess the Effect of Tocilizumab + Methotrexate on Signs and Symptoms in Patients With Moderate to Severe Active Rheumatoid Arthritis Currently on Methotrexate Therapy
  Malvern; Research Site:
  
  
• Rheumatoid Arthritis: A Study to Assess the Effect of Tocilizumab + Methotrexate on Signs and Symptoms in Patients With Moderate to Severe Active Rheumatoid Arthritis Currently on Methotrexate Therapy
  Shenton Park; Research Site:
  
  
• Rheumatoid Arthritis: A Study to Assess the Effect of Tocilizumab + Methotrexate on Signs and Symptoms in Patients With Moderate to Severe Active Rheumatoid Arthritis Currently on Methotrexate Therapy
  Sydney; Research Site:
  
  
• Rheumatoid Arthritis: A Study to Assess the Efficacy and Safety of MabThera (Rituximab) in Patients With Rheumatoid Arthritis
  Darlinghurst; Research Site:
  
  
• Rheumatoid Arthritis: A Study to Assess the Efficacy and Safety of MabThera (Rituximab) in Patients With Rheumatoid Arthritis
  Maroochydore; Research Site:
  
  
• Rheumatoid Arthritis: A Study to Assess the Efficacy and Safety of MabThera (Rituximab) in Patients With Rheumatoid Arthritis
  Melbourne; Research Site:
  
  
• Rheumatoid Arthritis: A Study to Assess the Efficacy and Safety of MabThera (Rituximab) in Patients With Rheumatoid Arthritis
  Perth; Research Site:
  
  
• Rheumatoid Arthritis: A Study to Assess the Efficacy and Safety of Retreatment With MabThera (Rituximab) in Patients With Active Rheumatoid Arthritis (RA)
  Maroochydore; Research Site:
  
  
• Rheumatoid Arthritis: A Study to Assess the Efficacy and Safety of Retreatment With MabThera (Rituximab) in Patients With Active Rheumatoid Arthritis (RA)
  Melbourne; Research Site:
  
  
• Rheumatoid Arthritis: A Study to Assess the Efficacy and Safety of Retreatment With MabThera (Rituximab) in Patients With Active Rheumatoid Arthritis (RA)
  Perth; Research Site:
  
  
• Rheumatoid Arthritis: A Study to Assess the Safety and Efficacy of Tocilizumab in Patients With Active Rheumatoid Arthritis
  Adelaide; Research Site:
  
  
• Rheumatoid Arthritis: A Study to Assess the Safety and Efficacy of Tocilizumab in Patients With Active Rheumatoid Arthritis
  Hobart; Research Site:
  
  
• Rheumatoid Arthritis: A Study to Assess the Safety and Efficacy of Tocilizumab in Patients With Active Rheumatoid Arthritis
  Shenton Park; Research Site:
  
  
• Rheumatoid Arthritis: A Study to Assess the Safety and Efficacy of Tocilizumab in Patients With Active Rheumatoid Arthritis
  Sydney; Research Site:
  
  
• Rheumatoid Arthritis: A Study to Assess the Safety and Efficacy of Tocilizumab in Patients With Active Rheumatoid Arthritis
  Woolloongabba; Research Site:
  
  
• Rheumatoid Arthritis: An Extension Study of Tocilizumab in Patients Completing Treatment in Tocilizumab Core Studies
  Hobart; Research Site:
  
  
• Rheumatoid Arthritis: An Extension Study of Tocilizumab in Patients Completing Treatment in Tocilizumab Core Studies
  Malvern; Research Site:
  
  
• Rheumatoid Arthritis: An Extension Study of Tocilizumab in Patients Completing Treatment in Tocilizumab Core Studies
  Shenton Park; Research Site:
  
  
• Rheumatoid Arthritis: An Extension Study of Tocilizumab in Patients Completing Treatment in Tocilizumab Core Studies
  Sydney; Research Site:
  
  
• Rheumatoid Arthritis: An Extension Study of Tocilizumab in Patients Completing Treatment in Tocilizumab Core Studies
  Woolloongabba; Research Site:
  
  

Austria

• Post-Menopausal Osteoporosis: BEATRIS study: A Study of Adherence to Bonviva (Ibandronate) Once Monthly in Women with Post-Menopausal Osteoporosis
  Bregenz; Research Site:
  
  
• Post-Menopausal Osteoporosis: BEATRIS study: A Study of Adherence to Bonviva (Ibandronate) Once Monthly in Women with Post-Menopausal Osteoporosis
  Graz; Research Site:
  
  
• Post-Menopausal Osteoporosis: BEATRIS study: A Study of Adherence to Bonviva (Ibandronate) Once Monthly in Women with Post-Menopausal Osteoporosis
  Innsbruck; Research Site:
  
  
• Post-Menopausal Osteoporosis: BEATRIS study: A Study of Adherence to Bonviva (Ibandronate) Once Monthly in Women with Post-Menopausal Osteoporosis
  Linz; Research Site:
  
  
• Post-Menopausal Osteoporosis: BEATRIS study: A Study of Adherence to Bonviva (Ibandronate) Once Monthly in Women with Post-Menopausal Osteoporosis
  Salzburg; Research Site:
  
  
• Post-Menopausal Osteoporosis: BEATRIS study: A Study of Adherence to Bonviva (Ibandronate) Once Monthly in Women with Post-Menopausal Osteoporosis
  Vöcklabruck; Research Site:
  
  
• Post-Menopausal Osteoporosis: BEATRIS study: A Study of Adherence to Bonviva (Ibandronate) Once Monthly in Women with Post-Menopausal Osteoporosis
  Wien; Research Site:
  
  
• Rheumatoid Arthritis: A Study of Ocrelizumab in Combination With Methotrexate in Patients With Rheumatoid Arthritis Who Are Naive to Methotrexate
  Klagenfurt; Research Site:
  
  
• Rheumatoid Arthritis: A Study of Ocrelizumab in Combination With Methotrexate in Patients With Rheumatoid Arthritis Who Are Naive to Methotrexate
  Wien; Research Site:
  
  
• Rheumatoid Arthritis: A Study of Ocrelizumab in Patients With Rheumatoid Arthritis Who Have an Inadequate Response to Methotrexate.
  Graz; Research Site:
  
  
• Rheumatoid Arthritis: A Study of Ocrelizumab in Patients With Rheumatoid Arthritis Who Have an Inadequate Response to Methotrexate.
  Salzburg; Research Site:
  
  
• Rheumatoid Arthritis: A Study of Ocrelizumab in Patients With Rheumatoid Arthritis Who Have an Inadequate Response to Methotrexate.
  Wien; Research Site:
  
  
• Rheumatoid Arthritis: A Study of Tocilizumab in Patients Completing Treatment in WA17822
  Wien; Research Site:
  
  
• Rheumatoid Arthritis: A Study to Assess the Effect of Tocilizumab + Methotrexate on Signs and Symptoms in Patients With Moderate to Severe Active Rheumatoid Arthritis
  Wien; Research Site:
  
  
• Rheumatoid Arthritis: Rheumatoid Arthritis (RA) Moderate to Low Disease Activity Study (CERTAIN)
  Wien; UCB Clinical Trial Call Center
  
  

Belgium

• Lupus: A Study of CellCept (Mycophenolate Mofetil) in Management of Patients With Lupus Nephritis.
  Bruxelles; Research Site:
  
  
• Multiple Sclerosis: A Dose-Finding Study of Ocrelizumab in Patients With Relapsing-Remitting Multiple Sclerosis.
  Edegem; Research Site:
  
  
• Multiple Sclerosis: A Dose-Finding Study of Ocrelizumab in Patients With Relapsing-Remitting Multiple Sclerosis.
  Sijsele-Damme; Research Site:
  
  
• Post-Menopausal Osteoporosis: A Study of Bonviva (Ibandronate) in Women With Post-Menopausal Osteoporosis
  Gent; Research Site:
  
  
• Post-Menopausal Osteoporosis: A Study of Bonviva (Ibandronate) in Women With Post-Menopausal Osteoporosis
  Leuven; Research Site:
  
  
• Post-Menopausal Osteoporosis: A Study of Bonviva (Ibandronate) in Women With Post-Menopausal Osteoporosis
  Liege; Research Site:
  
  
• Post-Menopausal Osteoporosis: A Study of Bonviva (Ibandronate) in Women With Post-Menopausal Osteoporosis Previously Treated With Bonviva
  Liege; Research Site:
  
  
• Post-Menopausal Osteoporosis: A Study of Bonviva (Ibandronate) in Women With Post-Menopausal Osteoporosis Previously Treated With Bonviva
  Merksem; Research Site:
  
  
• Post-Menopausal Osteoporosis: A Study of Bonviva (Ibandronate) in Women With Post-Menopausal Osteoporosis Who Have Received Previous Bonviva Treatment
  Bruxelles; Research Site:
  
  
• Post-Menopausal Osteoporosis: A Study of Bonviva (Ibandronate) in Women With Post-Menopausal Osteoporosis Who Have Received Previous Bonviva Treatment
  Liege; Research Site:
  
  
• Post-Menopausal Osteoporosis: BEATRIS study: A Study of Adherence to Bonviva (Ibandronate) Once Monthly in Women with Post-Menopausal Osteoporosis
  Aalst; Research Site:
  
  
• Post-Menopausal Osteoporosis: BEATRIS study: A Study of Adherence to Bonviva (Ibandronate) Once Monthly in Women with Post-Menopausal Osteoporosis
  Antwerpen; Research Site:
  
  
• Post-Menopausal Osteoporosis: BEATRIS study: A Study of Adherence to Bonviva (Ibandronate) Once Monthly in Women with Post-Menopausal Osteoporosis
  Aye; Research Site:
  
  
• Post-Menopausal Osteoporosis: BEATRIS study: A Study of Adherence to Bonviva (Ibandronate) Once Monthly in Women with Post-Menopausal Osteoporosis
  Braine L'Alleud; Research Site:
  
  
• Post-Menopausal Osteoporosis: BEATRIS study: A Study of Adherence to Bonviva (Ibandronate) Once Monthly in Women with Post-Menopausal Osteoporosis
  Brugge; Research Site:
  
  
• Post-Menopausal Osteoporosis: BEATRIS study: A Study of Adherence to Bonviva (Ibandronate) Once Monthly in Women with Post-Menopausal Osteoporosis
  Bruxelles; Research Site:
  
  
• Post-Menopausal Osteoporosis: BEATRIS study: A Study of Adherence to Bonviva (Ibandronate) Once Monthly in Women with Post-Menopausal Osteoporosis
  Charleroi; Research Site:
  
  
• Post-Menopausal Osteoporosis: BEATRIS study: A Study of Adherence to Bonviva (Ibandronate) Once Monthly in Women with Post-Menopausal Osteoporosis
  Dinant; Research Site:
  
  
• Post-Menopausal Osteoporosis: BEATRIS study: A Study of Adherence to Bonviva (Ibandronate) Once Monthly in Women with Post-Menopausal Osteoporosis
  Ekeren; Research Site:
  
  
• Post-Menopausal Osteoporosis: BEATRIS study: A Study of Adherence to Bonviva (Ibandronate) Once Monthly in Women with Post-Menopausal Osteoporosis
  Genk; Research Site:
  
  
• Post-Menopausal Osteoporosis: BEATRIS study: A Study of Adherence to Bonviva (Ibandronate) Once Monthly in Women with Post-Menopausal Osteoporosis
  Gent; Research Site:
  
  
• Post-Menopausal Osteoporosis: BEATRIS study: A Study of Adherence to Bonviva (Ibandronate) Once Monthly in Women with Post-Menopausal Osteoporosis
  Godinne; Research Site:
  
  
• Post-Menopausal Osteoporosis: BEATRIS study: A Study of Adherence to Bonviva (Ibandronate) Once Monthly in Women with Post-Menopausal Osteoporosis
  Hasselt; Research Site:
  
  
• Post-Menopausal Osteoporosis: BEATRIS study: A Study of Adherence to Bonviva (Ibandronate) Once Monthly in Women with Post-Menopausal Osteoporosis
  Jambes; Research Site:
  
  
• Post-Menopausal Osteoporosis: BEATRIS study: A Study of Adherence to Bonviva (Ibandronate) Once Monthly in Women with Post-Menopausal Osteoporosis
  Knokke; Research Site:
  
  
• Post-Menopausal Osteoporosis: BEATRIS study: A Study of Adherence to Bonviva (Ibandronate) Once Monthly in Women with Post-Menopausal Osteoporosis
  Kortrijk; Research Site:
  
  
• Post-Menopausal Osteoporosis: BEATRIS study: A Study of Adherence to Bonviva (Ibandronate) Once Monthly in Women with Post-Menopausal Osteoporosis
  La Louviere; Research Site:
  
  
• Post-Menopausal Osteoporosis: BEATRIS study: A Study of Adherence to Bonviva (Ibandronate) Once Monthly in Women with Post-Menopausal Osteoporosis
  Liege; Research Site:
  
  
• Post-Menopausal Osteoporosis: BEATRIS study: A Study of Adherence to Bonviva (Ibandronate) Once Monthly in Women with Post-Menopausal Osteoporosis
  Mechelen; Research Site:
  
  
• Post-Menopausal Osteoporosis: BEATRIS study: A Study of Adherence to Bonviva (Ibandronate) Once Monthly in Women with Post-Menopausal Osteoporosis
  Merksem; Research Site:
  
  
• Post-Menopausal Osteoporosis: BEATRIS study: A Study of Adherence to Bonviva (Ibandronate) Once Monthly in Women with Post-Menopausal Osteoporosis
  Mons; Research Site:
  
  
• Post-Menopausal Osteoporosis: BEATRIS study: A Study of Adherence to Bonviva (Ibandronate) Once Monthly in Women with Post-Menopausal Osteoporosis
  Oostende; Research Site:
  
  
• Post-Menopausal Osteoporosis: BEATRIS study: A Study of Adherence to Bonviva (Ibandronate) Once Monthly in Women with Post-Menopausal Osteoporosis
  Roeselare; Research Site:
  
  
• Post-Menopausal Osteoporosis: BEATRIS study: A Study of Adherence to Bonviva (Ibandronate) Once Monthly in Women with Post-Menopausal Osteoporosis
  Sijsele; Research Site:
  
  
• Post-Menopausal Osteoporosis: BEATRIS study: A Study of Adherence to Bonviva (Ibandronate) Once Monthly in Women with Post-Menopausal Osteoporosis
  Tournai; Research Site:
  
  
• Post-Menopausal Osteoporosis: BEATRIS study: A Study of Adherence to Bonviva (Ibandronate) Once Monthly in Women with Post-Menopausal Osteoporosis
  Turnhout; Research Site:
  
  
• Post-Menopausal Osteoporosis: BEATRIS study: A Study of Adherence to Bonviva (Ibandronate) Once Monthly in Women with Post-Menopausal Osteoporosis
  Waremme; Research Site:
  
  
• Post-Menopausal Osteoporosis: BEATRIS study: A Study of Adherence to Bonviva (Ibandronate) Once Monthly in Women with Post-Menopausal Osteoporosis
  Wilrijk; Research Site:
  
  
• Post-Menopausal Osteoporosis: DIVA Study - A Study of Different Regimens of Intravenous Administration of Bonviva (Ibandronate) in Women With Post-Menopausal Osteoporosis
  Bruxelles; Research Site:
  
  
• Post-Menopausal Osteoporosis: DIVA Study - A Study of Different Regimens of Intravenous Administration of Bonviva (Ibandronate) in Women With Post-Menopausal Osteoporosis
  Liege; Research Site:
  
  
• Post-Menopausal Osteoporosis: MOBILE Study - A Study of Bonviva (Ibandronate) Regimens in Women With Post-Menopausal Osteoporosis
  Liege; Research Site:
  
  
• Post-Menopausal Osteoporosis: MOBILE Study - A Study of Bonviva (Ibandronate) Regimens in Women With Post-Menopausal Osteoporosis
  Merksem; Research Site:
  
  
• Rheumatoid Arthritis: A Study of MabThera (Rituximab) in Combination With Methotrexate in Methotrexate-Naive Patients With Rheumatoid Arthritis (RA)
  Gent; Research Site:
  
  
• Rheumatoid Arthritis: A Study of Ocrelizumab in Patients With Rheumatoid Arthritis Who Have an Inadequate Response to anti-TNF-alpha Therapy.
  Brugge; Research Site:
  
  
• Rheumatoid Arthritis: A Study of Ocrelizumab in Patients With Rheumatoid Arthritis Who Have an Inadequate Response to anti-TNF-alpha Therapy.
  Bruxelles; Research Site:
  
  
• Rheumatoid Arthritis: A Study of Ocrelizumab in Patients With Rheumatoid Arthritis Who Have an Inadequate Response to anti-TNF-alpha Therapy.
  Charleroi; Research Site:
  
  
• Rheumatoid Arthritis: A Study of Ocrelizumab in Patients With Rheumatoid Arthritis Who Have an Inadequate Response to anti-TNF-alpha Therapy.
  Gent; Research Site:
  
  
• Rheumatoid Arthritis: A Study of Ocrelizumab in Patients With Rheumatoid Arthritis Who Have an Inadequate Response to anti-TNF-alpha Therapy.
  Leuven; Research Site:
  
  
• Rheumatoid Arthritis: A Study of Ocrelizumab in Patients With Rheumatoid Arthritis Who Have an Inadequate Response to anti-TNF-alpha Therapy.
  Merksem; Research Site:
  
  
• Rheumatoid Arthritis: A Study of Ocrelizumab in Patients With Rheumatoid Arthritis Who Have an Inadequate Response to anti-TNF-alpha Therapy.
  Montignies S/ Sambre; Research Site:
  
  
• Rheumatoid Arthritis: A Study of Ocrelizumab in Patients With Rheumatoid Arthritis Who Have an Inadequate Response to Methotrexate.
  Brugge; Research Site:
  
  
• Rheumatoid Arthritis: A Study of Ocrelizumab in Patients With Rheumatoid Arthritis Who Have an Inadequate Response to Methotrexate.
  Bruxelles; Research Site:
  
  
• Rheumatoid Arthritis: A Study of Ocrelizumab in Patients With Rheumatoid Arthritis Who Have an Inadequate Response to Methotrexate.
  Charleroi; Research Site:
  
  
• Rheumatoid Arthritis: A Study of Ocrelizumab in Patients With Rheumatoid Arthritis Who Have an Inadequate Response to Methotrexate.
  Gent; Research Site:
  
  
• Rheumatoid Arthritis: A Study of Ocrelizumab in Patients With Rheumatoid Arthritis Who Have an Inadequate Response to Methotrexate.
  Merksem; Research Site:
  
  
• Rheumatoid Arthritis: A Study of Ocrelizumab in Patients With Rheumatoid Arthritis Who Have an Inadequate Response to Methotrexate.
  Montignies S/ Sambre; Research Site:
  
  
• Rheumatoid Arthritis: A Study of Ocrelizumab in Patients With Rheumatoid Arthritis.
  Gent; Research Site:
  
  
• Rheumatoid Arthritis: A Study of Ocrelizumab in Patients With Rheumatoid Arthritis.
  Leuven; Research Site:
  
  
• Rheumatoid Arthritis: A Study of Retreatment With MabThera (Rituximab) in Combination With Methotrexate in Patients With Rheumatoid Arthritis (RA)
  Gent; Research Site:
  
  
• Rheumatoid Arthritis: A Study to Assess the Effect of Tocilizumab + Methotrexate on Signs and Symptoms in Patients With Moderate to Severe Active Rheumatoid Arthritis Currently on Methotrexate Therapy
  Aalst; Research Site:
  
  
• Rheumatoid Arthritis: A Study to Assess the Effect of Tocilizumab + Methotrexate on Signs and Symptoms in Patients With Moderate to Severe Active Rheumatoid Arthritis Currently on Methotrexate Therapy
  Hasselt; Research Site:
  
  
• Rheumatoid Arthritis: A Study to Assess the Effect of Tocilizumab + Methotrexate on Signs and Symptoms in Patients With Moderate to Severe Active Rheumatoid Arthritis Currently on Methotrexate Therapy
  Merksem; Research Site:
  
  
• Rheumatoid Arthritis: A Study to Assess the Efficacy and Safety of Retreatment With MabThera (Rituximab) in Patients With Active Rheumatoid Arthritis (RA)
  Gent; Research Site:
  
  
• Rheumatoid Arthritis: A Study to Assess the Safety and Efficacy of Retreatment With MabThera (Rituximab) in Patients With Rheumatoid Arthritis Who Have Failed on anti-TNFalfa Therapy
  Bruxelles; Research Site:
  
  
• Rheumatoid Arthritis: A Study to Assess the Safety and Efficacy of Retreatment With MabThera (Rituximab) in Patients With Rheumatoid Arthritis Who Have Failed on anti-TNFalfa Therapy
  Gent; Research Site:
  
  
• Rheumatoid Arthritis: A Study to Evaluate the Safety and Efficacy of MabThera (Rituximab) in Patients With Rheumatoid Arthritis Who Have Failed on Anti-TNFalfa Therapy
  Bruxelles; Research Site:
  
  
• Rheumatoid Arthritis: A Study to Evaluate the Safety and Efficacy of MabThera (Rituximab) in Patients With Rheumatoid Arthritis Who Have Failed on Anti-TNFalfa Therapy
  Gent; Research Site:
  
  
• Rheumatoid Arthritis: A Study to Evaluate the Safety and Efficacy of MabThera (Rituximab) in Patients With Rheumatoid Arthritis Who Have Failed on Anti-TNFalfa Therapy
  Liege; Research Site:
  
  
• Rheumatoid Arthritis: An Extension Study of Tocilizumab in Patients Completing Treatment in Tocilizumab Core Studies
  Hasselt; Research Site:
  
  
• Rheumatoid Arthritis: An Extension Study of Tocilizumab in Patients Completing Treatment in Tocilizumab Core Studies
  Merksem; Research Site:
  
  

Bosnia and Herzegovina

• Post-Menopausal Osteoporosis: BONCURE Study: A Study of Monthly Bonviva (Ibandronate) in Women With Post-Menopausal Osteoporosis on Bisphosphonate Therapy.
  Banja Luka; Research Site:
  
  
• Post-Menopausal Osteoporosis: BONCURE Study: A Study of Monthly Bonviva (Ibandronate) in Women With Post-Menopausal Osteoporosis on Bisphosphonate Therapy.
  Sarajevo; Research Site:
  
  
• Post-Menopausal Osteoporosis: BONCURE Study: A Study of Monthly Bonviva (Ibandronate) in Women With Post-Menopausal Osteoporosis on Bisphosphonate Therapy.
  Tuzla; Research Site:
  
  

Brazil

• Lupus: A Study of CellCept (Mycophenolate Mofetil) in Management of Patients With Lupus Nephritis.
  Rio De Janeiro; Research Site:
  
  
• Lupus: A Study of CellCept (Mycophenolate Mofetil) in Management of Patients With Lupus Nephritis.
  Sao Paulo; Research Site:
  
  
• Lupus: A Study of CellCept (Mycophenolate Mofetil) in Management of Patients With Lupus Nephritis.
  Sorocaba; Research Site:
  
  
• Post-Menopausal Osteoporosis: A Study of Bonviva (Ibandronate) and Alendronate on Renal Function in Postmenopausal Women With Osteoporosis at High Risk for Renal Disease.
  Brasilia; Research Site:
  
  
• Post-Menopausal Osteoporosis: A Study of Bonviva (Ibandronate) and Alendronate on Renal Function in Postmenopausal Women With Osteoporosis at High Risk for Renal Disease.
  Curitiba; Research Site:
  
  
• Post-Menopausal Osteoporosis: A Study of Bonviva (Ibandronate) and Alendronate on Renal Function in Postmenopausal Women With Osteoporosis at High Risk for Renal Disease.
  Goiania; Research Site:
  
  
• Post-Menopausal Osteoporosis: A Study of Bonviva (Ibandronate) and Alendronate on Renal Function in Postmenopausal Women With Osteoporosis at High Risk for Renal Disease.
  Porto Alegre; Research Site:
  
  
• Post-Menopausal Osteoporosis: A Study of Bonviva (Ibandronate) and Alendronate on Renal Function in Postmenopausal Women With Osteoporosis at High Risk for Renal Disease.
  Rio De Janeiro; Research Site:
  
  
• Post-Menopausal Osteoporosis: A Study of Bonviva (Ibandronate) and Alendronate on Renal Function in Postmenopausal Women With Osteoporosis at High Risk for Renal Disease.
  Sao Paulo; Research Site:
  
  
• Post-Menopausal Osteoporosis: A Study of Bonviva (Ibandronate) and Alendronate on Renal Function in Postmenopausal Women With Osteoporosis at High Risk for Renal Disease.
  Vitoria; Research Site:
  
  
• Post-Menopausal Osteoporosis: A Study of Bonviva (Ibandronate) in Women With Post-Menopausal Osteoporosis
  Brasilia; Research Site:
  
  
• Post-Menopausal Osteoporosis: A Study of Bonviva (Ibandronate) in Women With Post-Menopausal Osteoporosis
  Sao Paulo; Research Site:
  
  
• Post-Menopausal Osteoporosis: A Study of Bonviva (Ibandronate) in Women With Post-Menopausal Osteoporosis
  Vitoria; Research Site:
  
  
• Post-Menopausal Osteoporosis: A Study of Bonviva (Ibandronate) in Women With Post-Menopausal Osteoporosis Previously Treated With Bonviva
  Sao Paulo; Research Site:
  
  
• Post-Menopausal Osteoporosis: MOBILE Study - A Study of Bonviva (Ibandronate) Regimens in Women With Post-Menopausal Osteoporosis
  Campinas; Research Site:
  
  
• Post-Menopausal Osteoporosis: MOBILE Study - A Study of Bonviva (Ibandronate) Regimens in Women With Post-Menopausal Osteoporosis
  Curitiba; Research Site:
  
  
• Post-Menopausal Osteoporosis: MOBILE Study - A Study of Bonviva (Ibandronate) Regimens in Women With Post-Menopausal Osteoporosis
  Porto Alegre; Research Site:
  
  
• Post-Menopausal Osteoporosis: MOBILE Study - A Study of Bonviva (Ibandronate) Regimens in Women With Post-Menopausal Osteoporosis
  Sao Paulo; Research Site:
  
  
• Rheumatoid Arthritis: A Non-Comparative Study to Assess the Safety of MabThera (Rituximab) in Patients With Rheumatoid Arthritis.
  Belem; Research Site:
  
  
• Rheumatoid Arthritis: A Non-Comparative Study to Assess the Safety of MabThera (Rituximab) in Patients With Rheumatoid Arthritis.
  Brasilia; Research Site:
  
  
• Rheumatoid Arthritis: A Non-Comparative Study to Assess the Safety of MabThera (Rituximab) in Patients With Rheumatoid Arthritis.
  Campinas; Research Site:
  
  
• Rheumatoid Arthritis: A Non-Comparative Study to Assess the Safety of MabThera (Rituximab) in Patients With Rheumatoid Arthritis.
  Curitiba; Research Site:
  
  
• Rheumatoid Arthritis: A Non-Comparative Study to Assess the Safety of MabThera (Rituximab) in Patients With Rheumatoid Arthritis.
  Florianopolis; Research Site:
  
  
• Rheumatoid Arthritis: A Non-Comparative Study to Assess the Safety of MabThera (Rituximab) in Patients With Rheumatoid Arthritis.
  Fortaleza; Research Site:
  
  
• Rheumatoid Arthritis: A Non-Comparative Study to Assess the Safety of MabThera (Rituximab) in Patients With Rheumatoid Arthritis.
  Goiania; Research Site:
  
  
• Rheumatoid Arthritis: A Non-Comparative Study to Assess the Safety of MabThera (Rituximab) in Patients With Rheumatoid Arthritis.
  Nova Lima; Research Site:
  
  
• Rheumatoid Arthritis: A Non-Comparative Study to Assess the Safety of MabThera (Rituximab) in Patients With Rheumatoid Arthritis.
  Porto Alegre; Research Site:
  
  
• Rheumatoid Arthritis: A Non-Comparative Study to Assess the Safety of MabThera (Rituximab) in Patients With Rheumatoid Arthritis.
  Recife; Research Site:
  
  
• Rheumatoid Arthritis: A Non-Comparative Study to Assess the Safety of MabThera (Rituximab) in Patients With Rheumatoid Arthritis.
  Ribeirão Preto; Research Site:
  
  
• Rheumatoid Arthritis: A Non-Comparative Study to Assess the Safety of MabThera (Rituximab) in Patients With Rheumatoid Arthritis.
  Rio De Janeiro; Research Site:
  
  
• Rheumatoid Arthritis: A Non-Comparative Study to Assess the Safety of MabThera (Rituximab) in Patients With Rheumatoid Arthritis.
  Salvador; Research Site:
  
  
• Rheumatoid Arthritis: A Non-Comparative Study to Assess the Safety of MabThera (Rituximab) in Patients With Rheumatoid Arthritis.
  Sao Paulo; Research Site:
  
  
• Rheumatoid Arthritis: A Non-Comparative Study to Assess the Safety of MabThera (Rituximab) in Patients With Rheumatoid Arthritis.
  Vitoria; Research Site:
  
  
• Rheumatoid Arthritis: A Study of MabThera (Rituximab) in Combination With Methotrexate in Methotrexate-Naive Patients With Rheumatoid Arthritis (RA)
  Brasilia; Research Site:
  
  
• Rheumatoid Arthritis: A Study of MabThera (Rituximab) in Combination With Methotrexate in Methotrexate-Naive Patients With Rheumatoid Arthritis (RA)
  Curitiba; Research Site:
  
  
• Rheumatoid Arthritis: A Study of MabThera (Rituximab) in Combination With Methotrexate in Methotrexate-Naive Patients With Rheumatoid Arthritis (RA)
  Goiania; Research Site:
  
  
• Rheumatoid Arthritis: A Study of MabThera (Rituximab) in Combination With Methotrexate in Methotrexate-Naive Patients With Rheumatoid Arthritis (RA)
  Sao Paulo; Research Site:
  
  
• Rheumatoid Arthritis: A Study of Ocrelizumab Given as a Single or Dual Infusion in Patients With Rheumatoid Arthritis Who Have an Inadequate Response to Methotrexate
  Brasilia; Research Site:
  
  
• Rheumatoid Arthritis: A Study of Ocrelizumab Given as a Single or Dual Infusion in Patients With Rheumatoid Arthritis Who Have an Inadequate Response to Methotrexate
  Campinas; Research Site:
  
  
• Rheumatoid Arthritis: A Study of Ocrelizumab Given as a Single or Dual Infusion in Patients With Rheumatoid Arthritis Who Have an Inadequate Response to Methotrexate
  Goiania; Research Site:
  
  
• Rheumatoid Arthritis: A Study of Ocrelizumab Given as a Single or Dual Infusion in Patients With Rheumatoid Arthritis Who Have an Inadequate Response to Methotrexate
  Juiz De Fora; Research Site:
  
  
• Rheumatoid Arthritis: A Study of Ocrelizumab Given as a Single or Dual Infusion in Patients With Rheumatoid Arthritis Who Have an Inadequate Response to Methotrexate
  Rio De Janeiro; Research Site:
  
  
• Rheumatoid Arthritis: A Study of Ocrelizumab Given as a Single or Dual Infusion in Patients With Rheumatoid Arthritis Who Have an Inadequate Response to Methotrexate
  Sao Paulo; Research Site:
  
  
• Rheumatoid Arthritis: A Study of Ocrelizumab in Combination With Methotrexate in Patients With Rheumatoid Arthritis Who Are Naive to Methotrexate
  Curitiba; Research Site:
  
  
• Rheumatoid Arthritis: A Study of Ocrelizumab in Combination With Methotrexate in Patients With Rheumatoid Arthritis Who Are Naive to Methotrexate
  Goiania; Research Site:
  
  
• Rheumatoid Arthritis: A Study of Ocrelizumab in Combination With Methotrexate in Patients With Rheumatoid Arthritis Who Are Naive to Methotrexate
  Porto Alegre; Research Site:
  
  
• Rheumatoid Arthritis: A Study of Ocrelizumab in Combination With Methotrexate in Patients With Rheumatoid Arthritis Who Are Naive to Methotrexate
  Sao Paulo; Research Site:
  
  
• Rheumatoid Arthritis: A Study of Ocrelizumab in Patients With Rheumatoid Arthritis Who Have an Inadequate Response to anti-TNF-alpha Therapy.
  Campinas; Research Site:
  
  
• Rheumatoid Arthritis: A Study of Ocrelizumab in Patients With Rheumatoid Arthritis Who Have an Inadequate Response to anti-TNF-alpha Therapy.
  Curitiba; Research Site:
  
  
• Rheumatoid Arthritis: A Study of Ocrelizumab in Patients With Rheumatoid Arthritis Who Have an Inadequate Response to anti-TNF-alpha Therapy.
  Goiania; Research Site:
  
  
• Rheumatoid Arthritis: A Study of Ocrelizumab in Patients With Rheumatoid Arthritis Who Have an Inadequate Response to anti-TNF-alpha Therapy.
  Porto Alegre; Research Site:
  
  
• Rheumatoid Arthritis: A Study of Ocrelizumab in Patients With Rheumatoid Arthritis Who Have an Inadequate Response to anti-TNF-alpha Therapy.
  Ribeirão Preto; Research Site:
  
  
• Rheumatoid Arthritis: A Study of Ocrelizumab in Patients With Rheumatoid Arthritis Who Have an Inadequate Response to anti-TNF-alpha Therapy.
  Rio De Janeiro; Research Site:
  
  
• Rheumatoid Arthritis: A Study of Ocrelizumab in Patients With Rheumatoid Arthritis Who Have an Inadequate Response to anti-TNF-alpha Therapy.
  Sao Paulo; Research Site:
  
  
• Rheumatoid Arthritis: A Study of Ocrelizumab in Patients With Rheumatoid Arthritis Who Have an Inadequate Response to Methotrexate.
  Curitiba; Research Site:
  
  
• Rheumatoid Arthritis: A Study of Ocrelizumab in Patients With Rheumatoid Arthritis Who Have an Inadequate Response to Methotrexate.
  Goiania; Research Site:
  
  
• Rheumatoid Arthritis: A Study of Ocrelizumab in Patients With Rheumatoid Arthritis Who Have an Inadequate Response to Methotrexate.
  Porto Alegre; Research Site:
  
  
• Rheumatoid Arthritis: A Study of Ocrelizumab in Patients With Rheumatoid Arthritis Who Have an Inadequate Response to Methotrexate.
  Rio De Janeiro; Research Site:
  
  
• Rheumatoid Arthritis: A Study of Ocrelizumab in Patients With Rheumatoid Arthritis Who Have an Inadequate Response to Methotrexate.
  Sao Paulo; Research Site:
  
  
• Rheumatoid Arthritis: A Study of P38 Inhibitor (4) in Patients With Active Rheumatoid Arthritis (RA) on Stable Methotrexate Therapy
  Curitiba; Research Site:
  
  
• Rheumatoid Arthritis: A Study of P38 Inhibitor (4) in Patients With Active Rheumatoid Arthritis (RA) on Stable Methotrexate Therapy
  Goiania; Research Site:
  
  
• Rheumatoid Arthritis: A Study of P38 Inhibitor (4) in Patients With Active Rheumatoid Arthritis (RA) on Stable Methotrexate Therapy
  Sao Paulo; Research Site:
  
  
• Rheumatoid Arthritis: A Study of Retreatment With MabThera (Rituximab) in Combination With Methotrexate in Patients With Rheumatoid Arthritis (RA)
  Goiania; Research Site:
  
  
• Rheumatoid Arthritis: A Study of Retreatment With MabThera (Rituximab) in Combination With Methotrexate in Patients With Rheumatoid Arthritis (RA)
  Sao Paulo; Research Site:
  
  
• Rheumatoid Arthritis: A Study of Tocilizumab in Patients Completing Treatment in WA17822
  Porto Alegre; Research Site:
  
  
• Rheumatoid Arthritis: A Study of Tocilizumab in Patients Completing Treatment in WA17822
  Sao Paulo; Research Site:
  
  
• Rheumatoid Arthritis: A Study to Assess the Effect of Tocilizumab + DMARD Therapy on Signs and Symptoms in Patients With Moderate to Severe Active Rheumatoid Arthritis
  Campinas; Research Site:
  
  
• Rheumatoid Arthritis: A Study to Assess the Effect of Tocilizumab + DMARD Therapy on Signs and Symptoms in Patients With Moderate to Severe Active Rheumatoid Arthritis
  Goiania; Research Site:
  
  
• Rheumatoid Arthritis: A Study to Assess the Effect of Tocilizumab + DMARD Therapy on Signs and Symptoms in Patients With Moderate to Severe Active Rheumatoid Arthritis
  Rio De Janeiro; Research Site:
  
  
• Rheumatoid Arthritis: A Study to Assess the Effect of Tocilizumab + Methotrexate on Prevention of Structural Joint Damage in Patients With Moderate to Severe Active Rheumatoid Arthritis
  Porto Alegre; Research Site:
  
  
• Rheumatoid Arthritis: A Study to Assess the Effect of Tocilizumab + Methotrexate on Prevention of Structural Joint Damage in Patients With Moderate to Severe Active Rheumatoid Arthritis
  Rio De Janeiro; Research Site:
  
  
• Rheumatoid Arthritis: A Study to Assess the Effect of Tocilizumab + Methotrexate on Prevention of Structural Joint Damage in Patients With Moderate to Severe Active Rheumatoid Arthritis
  Sao Paulo; Research Site:
  
  
• Rheumatoid Arthritis: A Study to Assess the Effect of Tocilizumab + Methotrexate on Signs and Symptoms in Patients With Moderate to Severe Active Rheumatoid Arthritis
  Porto Alegre; Research Site:
  
  
• Rheumatoid Arthritis: A Study to Assess the Effect of Tocilizumab + Methotrexate on Signs and Symptoms in Patients With Moderate to Severe Active Rheumatoid Arthritis
  Sao Paulo; Research Site:
  
  
• Rheumatoid Arthritis: A Study to Assess the Efficacy and Safety of MabThera (Rituximab) in Patients With Rheumatoid Arthritis
  Campinas; Research Site:
  
  
• Rheumatoid Arthritis: A Study to Assess the Efficacy and Safety of MabThera (Rituximab) in Patients With Rheumatoid Arthritis
  Curitiba; Research Site:
  
  
• Rheumatoid Arthritis: A Study to Assess the Efficacy and Safety of MabThera (Rituximab) in Patients With Rheumatoid Arthritis
  Sao Paulo; Research Site:
  
  
• Rheumatoid Arthritis: A Study to Assess the Efficacy and Safety of Retreatment With MabThera (Rituximab) in Patients With Active Rheumatoid Arthritis (RA)
  Campinas; Research Site:
  
  
• Rheumatoid Arthritis: A Study to Assess the Efficacy and Safety of Retreatment With MabThera (Rituximab) in Patients With Active Rheumatoid Arthritis (RA)
  Curitiba; Research Site:
  
  
• Rheumatoid Arthritis: A Study to Assess the Efficacy and Safety of Retreatment With MabThera (Rituximab) in Patients With Active Rheumatoid Arthritis (RA)
  Sao Paulo; Research Site:
  
  
• Rheumatoid Arthritis: An Extension Study of Tocilizumab in Patients Completing Treatment in Tocilizumab Core Studies
  Campinas; Research Site:
  
  
• Rheumatoid Arthritis: An Extension Study of Tocilizumab in Patients Completing Treatment in Tocilizumab Core Studies
  Goiania; Research Site:
  
  
• Rheumatoid Arthritis: An Extension Study of Tocilizumab in Patients Completing Treatment in Tocilizumab Core Studies
  Rio De Janeiro; Research Site:
  
  
• Rheumatoid Arthritis: SCORE Study: A Study of MabThera (Rituximab) in Patients With Rheumatoid Arthritis and Inadequate Response to Methotrexate.
  Curitiba; Research Site:
  
  
• Rheumatoid Arthritis: SCORE Study: A Study of MabThera (Rituximab) in Patients With Rheumatoid Arthritis and Inadequate Response to Methotrexate.
  Goiania; Research Site:
  
  
• Rheumatoid Arthritis: SCORE Study: A Study of MabThera (Rituximab) in Patients With Rheumatoid Arthritis and Inadequate Response to Methotrexate.
  Porto Alegre; Research Site:
  
  
• Rheumatoid Arthritis: SCORE Study: A Study of MabThera (Rituximab) in Patients With Rheumatoid Arthritis and Inadequate Response to Methotrexate.
  Sao Paulo; Research Site:
  
  
• Systemic Lupus Erythematosus: A Study of Ocrelizumab in Patients With Nephritis Due to Systemic Lupus Erythematosus.
  Belo Horizonte; Research Site:
  
  
• Systemic Lupus Erythematosus: A Study of Ocrelizumab in Patients With Nephritis Due to Systemic Lupus Erythematosus.
  Brasilia; Research Site:
  
  
• Systemic Lupus Erythematosus: A Study of Ocrelizumab in Patients With Nephritis Due to Systemic Lupus Erythematosus.
  Curitiba; Research Site:
  
  
• Systemic Lupus Erythematosus: A Study of Ocrelizumab in Patients With Nephritis Due to Systemic Lupus Erythematosus.
  Fortaleza; Research Site:
  
  
• Systemic Lupus Erythematosus: A Study of Ocrelizumab in Patients With Nephritis Due to Systemic Lupus Erythematosus.
  Goiania; Research Site:
  
  
• Systemic Lupus Erythematosus: A Study of Ocrelizumab in Patients With Nephritis Due to Systemic Lupus Erythematosus.
  Marilia; Research Site:
  
  
• Systemic Lupus Erythematosus: A Study of Ocrelizumab in Patients With Nephritis Due to Systemic Lupus Erythematosus.
  Porto Alegre; Research Site:
  
  
• Systemic Lupus Erythematosus: A Study of Ocrelizumab in Patients With Nephritis Due to Systemic Lupus Erythematosus.
  Recife; Research Site:
  
  
• Systemic Lupus Erythematosus: A Study of Ocrelizumab in Patients With Nephritis Due to Systemic Lupus Erythematosus.
  Ribeirão Preto; Research Site:
  
  
• Systemic Lupus Erythematosus: A Study of Ocrelizumab in Patients With Nephritis Due to Systemic Lupus Erythematosus.
  Rio De Janeiro; Research Site:
  
  
• Systemic Lupus Erythematosus: A Study of Ocrelizumab in Patients With Nephritis Due to Systemic Lupus Erythematosus.
  Sao Paulo; Research Site:
  
  
• Systemic Lupus Erythematosus: A Study of Ocrelizumab in Patients With Systemic Lupus Erythematosus.
  Belo Horizonte; Research Site:
  
  
• Systemic Lupus Erythematosus: A Study of Ocrelizumab in Patients With Systemic Lupus Erythematosus.
  Brasilia; Research Site:
  
  
• Systemic Lupus Erythematosus: A Study of Ocrelizumab in Patients With Systemic Lupus Erythematosus.
  Curitiba; Research Site:
  
  
• Systemic Lupus Erythematosus: A Study of Ocrelizumab in Patients With Systemic Lupus Erythematosus.
  Fortaleza; Research Site:
  
  
• Systemic Lupus Erythematosus: A Study of Ocrelizumab in Patients With Systemic Lupus Erythematosus.
  Goiania; Research Site:
  
  
• Systemic Lupus Erythematosus: A Study of Ocrelizumab in Patients With Systemic Lupus Erythematosus.
  Porto Alegre; Research Site:
  
  
• Systemic Lupus Erythematosus: A Study of Ocrelizumab in Patients With Systemic Lupus Erythematosus.
  Recife; Research Site:
  
  
• Systemic Lupus Erythematosus: A Study of Ocrelizumab in Patients With Systemic Lupus Erythematosus.
  Ribeirão Preto; Research Site:
  
  
• Systemic Lupus Erythematosus: A Study of Ocrelizumab in Patients With Systemic Lupus Erythematosus.
  Rio De Janeiro; Research Site:
  
  
• Systemic Lupus Erythematosus: A Study of Ocrelizumab in Patients With Systemic Lupus Erythematosus.
  Sao Paulo; Research Site:
  
  

Bulgaria

• Multiple Sclerosis: A Dose-Finding Study of Ocrelizumab in Patients With Relapsing-Remitting Multiple Sclerosis.
  Sofia; Research Site:
  
  
• Rheumatoid Arthritis: A Study of Tocilizumab in Patients Completing Treatment in WA17822
  Sofia; Research Site:
  
  
• Rheumatoid Arthritis: A Study of Tocilizumab in Patients Completing Treatment in WA17822
  Varna; Research Site:
  
  
• Rheumatoid Arthritis: A Study to Assess the Effect of Tocilizumab + Methotrexate on Signs and Symptoms in Patients With Moderate to Severe Active Rheumatoid Arthritis
  Sofia; Research Site:
  
  
• Rheumatoid Arthritis: A Study to Assess the Effect of Tocilizumab + Methotrexate on Signs and Symptoms in Patients With Moderate to Severe Active Rheumatoid Arthritis
  Varna; Research Site:
  
  
• Systemic Lupus Erythematosus: A Study of Ocrelizumab in Patients With Nephritis Due to Systemic Lupus Erythematosus.
  Pleven; Research Site:
  
  
• Systemic Lupus Erythematosus: A Study of Ocrelizumab in Patients With Nephritis Due to Systemic Lupus Erythematosus.
  Sofia; Research Site:
  
  
• Systemic Lupus Erythematosus: A Study of Ocrelizumab in Patients With Systemic Lupus Erythematosus.
  Pleven; Research Site:
  
  
• Systemic Lupus Erythematosus: A Study of Ocrelizumab in Patients With Systemic Lupus Erythematosus.
  Sofia; Research Site:
  
  

Canada

• Bone Density: A four month study with an eight month extension will evaluate the safety and long term usefulness of an osteoporosis medication in post-menopausal female subjects with low bone mineral density (BMD).
  Montreal, QC; Montreal Clinical Study Centre Inc.
  
  
• Bone Metastases: A clinical study to evaluate the effect of a new treatment in patients with Prostate or Breast Cancer with Metastatic Bone Disease
  Edmonton, AB; Cross Cancer Institute
  
  
• Bone Metastases: A clinical study to evaluate the effect of a new treatment in patients with Prostate or Breast Cancer with Metastatic Bone Disease
  Montreal, QC; Hospital Notre Dame
  
  
• Bone Metastases: A Pivotal Study to Evaluate the Effectiveness and Safety of ExAblate Treatment of Metastatic Bone Tumors for the Palliation of Pain in Patients Who are not Candidates for Radiation Therapy
  Toronto, Ontario; Toronto General Hospital
  
  
• Lupus: A Study of CellCept (Mycophenolate Mofetil) in Management of Patients With Lupus Nephritis.
  Montreal, QC; Research Site:
  
  
• Multiple Sclerosis: A Dose-Finding Study of Ocrelizumab in Patients With Relapsing-Remitting Multiple Sclerosis.
  Toronto, ON; Research Site:
  
  
• Multiple Sclerosis: A Dose-Finding Study of Ocrelizumab in Patients With Relapsing-Remitting Multiple Sclerosis.
  Vancouver, BC; Research Site:
  
  
• Myasthenia Gravis generalised: A Study to Assess the Effect of CellCept (Mycophenolate Mofetil) and Reduced Corticosteroids in Controlling Symptoms of Myasthenia Gravis
  Edmonton, AB; Research Site:
  
  
• Myasthenia Gravis generalised: A Study to Assess the Effect of CellCept (Mycophenolate Mofetil) and Reduced Corticosteroids in Controlling Symptoms of Myasthenia Gravis
  London, ON; Research Site:
  
  
• Post-Menopausal Osteoporosis: DIVA Study - A Study of Different Regimens of Intravenous Administration of Bonviva (Ibandronate) in Women With Post-Menopausal Osteoporosis
  Laval, QC; Research Site:
  
  
• Post-Menopausal Osteoporosis: DIVA Study - A Study of Different Regimens of Intravenous Administration of Bonviva (Ibandronate) in Women With Post-Menopausal Osteoporosis
  Montreal, QC; Research Site:
  
  
• Post-Menopausal Osteoporosis: DIVA Study - A Study of Different Regimens of Intravenous Administration of Bonviva (Ibandronate) in Women With Post-Menopausal Osteoporosis
  Saskatoon, SK; Research Site:
  
  
• Post-Menopausal Osteoporosis: DIVA Study - A Study of Different Regimens of Intravenous Administration of Bonviva (Ibandronate) in Women With Post-Menopausal Osteoporosis
  Toronto, ON; Research Site:
  
  
• Post-Menopausal Osteoporosis: MOBILE Study - A Study of Bonviva (Ibandronate) Regimens in Women With Post-Menopausal Osteoporosis
  Calgary, AB; Research Site:
  
  
• Post-Menopausal Osteoporosis: MOBILE Study - A Study of Bonviva (Ibandronate) Regimens in Women With Post-Menopausal Osteoporosis
  Quebec City, QC; Research Site:
  
  
• Post-Menopausal Osteoporosis: MOBILE Study - A Study of Bonviva (Ibandronate) Regimens in Women With Post-Menopausal Osteoporosis
  Toronto, ON; Research Site:
  
  
• Post-Menopausal Osteoporosis: MOBILE Study - A Study of Bonviva (Ibandronate) Regimens in Women With Post-Menopausal Osteoporosis
  Vancouver, BC; Research Site:
  
  
• Rheumatoid Arthritis: A Study of MabThera (Rituximab) in Combination With Methotrexate in Methotrexate-Naive Patients With Rheumatoid Arthritis (RA)
  Burlington, ON; Research Site:
  
  
• Rheumatoid Arthritis: A Study of MabThera (Rituximab) in Combination With Methotrexate in Methotrexate-Naive Patients With Rheumatoid Arthritis (RA)
  Calgary, AB; Research Site:
  
  
• Rheumatoid Arthritis: A Study of MabThera (Rituximab) in Combination With Methotrexate in Methotrexate-Naive Patients With Rheumatoid Arthritis (RA)
  Ottawa, ON; Research Site:
  
  
• Rheumatoid Arthritis: A Study of MabThera (Rituximab) in Combination With Methotrexate in Methotrexate-Naive Patients With Rheumatoid Arthritis (RA)
  Quebec City, QC; Research Site:
  
  
• Rheumatoid Arthritis: A Study of MabThera (Rituximab) in Combination With Methotrexate in Methotrexate-Naive Patients With Rheumatoid Arthritis (RA)
  Sherbrooke, QC; Research Site:
  
  
• Rheumatoid Arthritis: A Study of MabThera (Rituximab) in Combination With Methotrexate in Methotrexate-Naive Patients With Rheumatoid Arthritis (RA)
  St John'S; Research Site:
  
  
• Rheumatoid Arthritis: A Study of MabThera (Rituximab) in Combination With Methotrexate in Methotrexate-Naive Patients With Rheumatoid Arthritis (RA)
  Toronto, ON; Research Site:
  
  
• Rheumatoid Arthritis: A Study of MabThera (Rituximab) in Combination With Methotrexate in Methotrexate-Naive Patients With Rheumatoid Arthritis (RA)
  Trois-Rivieres, QC; Research Site:
  
  
• Rheumatoid Arthritis: A Study of MabThera (Rituximab) in Combination With Methotrexate in Methotrexate-Naive Patients With Rheumatoid Arthritis (RA)
  Vancouver, BC; Research Site:
  
  
• Rheumatoid Arthritis: A Study of MabThera (Rituximab) in Combination With Methotrexate in Patients With Rheumatoid Arthritis (RA)
  Hamilton, ON; Research Site:
  
  
• Rheumatoid Arthritis: A Study of MabThera (Rituximab) in Combination With Methotrexate in Patients With Rheumatoid Arthritis (RA)
  Kitchener, ON; Research Site:
  
  
• Rheumatoid Arthritis: A Study of MabThera (Rituximab) in Combination With Methotrexate in Patients With Rheumatoid Arthritis (RA)
  Saskatoon, SK; Research Site:
  
  
• Rheumatoid Arthritis: A Study of MabThera (Rituximab) in Patients With Rheumatoid Arthritis Who Have Failed on One Prior anti-TNF Therapy.
  Edmonton, AB; Research Site:
  
  
• Rheumatoid Arthritis: A Study of MabThera (Rituximab) in Patients With Rheumatoid Arthritis Who Have Failed on One Prior anti-TNF Therapy.
  Hamilton, ON; Research Site:
  
  
• Rheumatoid Arthritis: A Study of MabThera (Rituximab) in Patients With Rheumatoid Arthritis Who Have Failed on One Prior anti-TNF Therapy.
  Kelowna, BC; Research Site:
  
  
• Rheumatoid Arthritis: A Study of MabThera (Rituximab) in Patients With Rheumatoid Arthritis Who Have Failed on One Prior anti-TNF Therapy.
  Laval, QC; Research Site:
  
  
• Rheumatoid Arthritis: A Study of MabThera (Rituximab) in Patients With Rheumatoid Arthritis Who Have Failed on One Prior anti-TNF Therapy.
  Mississauga, ON; Research Site:
  
  
• Rheumatoid Arthritis: A Study of MabThera (Rituximab) in Patients With Rheumatoid Arthritis Who Have Failed on One Prior anti-TNF Therapy.
  Montreal, QC; Research Site:
  
  
• Rheumatoid Arthritis: A Study of MabThera (Rituximab) in Patients With Rheumatoid Arthritis Who Have Failed on One Prior anti-TNF Therapy.
  Nepean, ON; Research Site:
  
  
• Rheumatoid Arthritis: A Study of MabThera (Rituximab) in Patients With Rheumatoid Arthritis Who Have Failed on One Prior anti-TNF Therapy.
  Ottawa, ON; Research Site:
  
  
• Rheumatoid Arthritis: A Study of MabThera (Rituximab) in Patients With Rheumatoid Arthritis Who Have Failed on One Prior anti-TNF Therapy.
  Quebec City, QC; Research Site:
  
  
• Rheumatoid Arthritis: A Study of MabThera (Rituximab) in Patients With Rheumatoid Arthritis Who Have Failed on One Prior anti-TNF Therapy.
  Sainte-Foy, QC; Research Site:
  
  
• Rheumatoid Arthritis: A Study of MabThera (Rituximab) in Patients With Rheumatoid Arthritis Who Have Failed on One Prior anti-TNF Therapy.
  Sherbrooke, QC; Research Site:
  
  
• Rheumatoid Arthritis: A Study of MabThera (Rituximab) in Patients With Rheumatoid Arthritis Who Have Failed on One Prior anti-TNF Therapy.
  St John'S; Research Site:
  
  
• Rheumatoid Arthritis: A Study of MabThera (Rituximab) in Patients With Rheumatoid Arthritis Who Have Failed on One Prior anti-TNF Therapy.
  St-Eustache, QC; Research Site:
  
  
• Rheumatoid Arthritis: A Study of MabThera (Rituximab) in Patients With Rheumatoid Arthritis Who Have Failed on One Prior anti-TNF Therapy.
  Thunder Bay, ON; Research Site:
  
  
• Rheumatoid Arthritis: A Study of MabThera (Rituximab) in Patients With Rheumatoid Arthritis Who Have Failed on One Prior anti-TNF Therapy.
  Toronto, ON; Research Site:
  
  
• Rheumatoid Arthritis: A Study of MabThera (Rituximab) in Patients With Rheumatoid Arthritis Who Have Failed on One Prior anti-TNF Therapy.
  Trois-Rivieres, QC; Research Site:
  
  
• Rheumatoid Arthritis: A Study of MabThera (Rituximab) in Patients With Rheumatoid Arthritis Who Have Failed on One Prior anti-TNF Therapy.
  Vancouver, BC; Research Site:
  
  
• Rheumatoid Arthritis: A Study of MabThera (Rituximab) in Patients With Rheumatoid Arthritis Who Have Failed on One Prior anti-TNF Therapy.
  Victoria, BC; Research Site:
  
  
• Rheumatoid Arthritis: A Study of MabThera (Rituximab) in Patients With Rheumatoid Arthritis Who Have Failed on One Prior anti-TNF Therapy.
  Windsor, ON; Research Site:
  
  
• Rheumatoid Arthritis: A Study of MabThera (Rituximab) in Patients With Rheumatoid Arthritis Who Have Failed on One Prior anti-TNF Therapy.
  Winnipeg, MB; Research Site:
  
  
• Rheumatoid Arthritis: A Study of Ocrelizumab Given as a Single or Dual Infusion in Patients With Rheumatoid Arthritis Who Have an Inadequate Response to Methotrexate
  Calgary, AB; Research Site:
  
  
• Rheumatoid Arthritis: A Study of Ocrelizumab Given as a Single or Dual Infusion in Patients With Rheumatoid Arthritis Who Have an Inadequate Response to Methotrexate
  Hamilton, ON; Research Site:
  
  
• Rheumatoid Arthritis: A Study of Ocrelizumab Given as a Single or Dual Infusion in Patients With Rheumatoid Arthritis Who Have an Inadequate Response to Methotrexate
  Ottawa, ON; Research Site:
  
  
• Rheumatoid Arthritis: A Study of Ocrelizumab Given as a Single or Dual Infusion in Patients With Rheumatoid Arthritis Who Have an Inadequate Response to Methotrexate
  Winnipeg, MB; Research Site:
  
  
• Rheumatoid Arthritis: A Study of Ocrelizumab in Patients With Rheumatoid Arthritis Who Have an Inadequate Response to anti-TNF-alpha Therapy.
  Burlington, ON; Research Site:
  
  
• Rheumatoid Arthritis: A Study of Ocrelizumab in Patients With Rheumatoid Arthritis Who Have an Inadequate Response to anti-TNF-alpha Therapy.
  Edmonton, AB; Research Site:
  
  
• Rheumatoid Arthritis: A Study of Ocrelizumab in Patients With Rheumatoid Arthritis Who Have an Inadequate Response to anti-TNF-alpha Therapy.
  Hamilton, ON; Research Site:
  
  
• Rheumatoid Arthritis: A Study of Ocrelizumab in Patients With Rheumatoid Arthritis Who Have an Inadequate Response to anti-TNF-alpha Therapy.
  Kitchener, ON; Research Site:
  
  
• Rheumatoid Arthritis: A Study of Ocrelizumab in Patients With Rheumatoid Arthritis Who Have an Inadequate Response to anti-TNF-alpha Therapy.
  London, ON; Research Site:
  
  
• Rheumatoid Arthritis: A Study of Ocrelizumab in Patients With Rheumatoid Arthritis Who Have an Inadequate Response to anti-TNF-alpha Therapy.
  Mississauga, ON; Research Site:
  
  
• Rheumatoid Arthritis: A Study of Ocrelizumab in Patients With Rheumatoid Arthritis Who Have an Inadequate Response to anti-TNF-alpha Therapy.
  Montreal, QC; Research Site:
  
  
• Rheumatoid Arthritis: A Study of Ocrelizumab in Patients With Rheumatoid Arthritis Who Have an Inadequate Response to anti-TNF-alpha Therapy.
  Ottawa, ON; Research Site:
  
  
• Rheumatoid Arthritis: A Study of Ocrelizumab in Patients With Rheumatoid Arthritis Who Have an Inadequate Response to anti-TNF-alpha Therapy.
  Quebec City, QC; Research Site:
  
  
• Rheumatoid Arthritis: A Study of Ocrelizumab in Patients With Rheumatoid Arthritis Who Have an Inadequate Response to anti-TNF-alpha Therapy.
  Saskatoon, SK; Research Site:
  
  
• Rheumatoid Arthritis: A Study of Ocrelizumab in Patients With Rheumatoid Arthritis Who Have an Inadequate Response to anti-TNF-alpha Therapy.
  Toronto, ON; Research Site:
  
  
• Rheumatoid Arthritis: A Study of Ocrelizumab in Patients With Rheumatoid Arthritis Who Have an Inadequate Response to anti-TNF-alpha Therapy.
  Trois-Rivieres, QC; Research Site:
  
  
• Rheumatoid Arthritis: A Study of Ocrelizumab in Patients With Rheumatoid Arthritis Who Have an Inadequate Response to anti-TNF-alpha Therapy.
  Vancouver, BC; Research Site:
  
  
• Rheumatoid Arthritis: A Study of Ocrelizumab in Patients With Rheumatoid Arthritis Who Have an Inadequate Response to anti-TNF-alpha Therapy.
  Winnipeg, MB; Research Site:
  
  
• Rheumatoid Arthritis: A Study of Ocrelizumab in Patients With Rheumatoid Arthritis Who Have an Inadequate Response to Methotrexate.
  Hamilton, ON; Research Site:
  
  
• Rheumatoid Arthritis: A Study of Ocrelizumab in Patients With Rheumatoid Arthritis Who Have an Inadequate Response to Methotrexate.
  Kitchener, ON; Research Site:
  
  
• Rheumatoid Arthritis: A Study of Ocrelizumab in Patients With Rheumatoid Arthritis Who Have an Inadequate Response to Methotrexate.
  London, ON; Research Site:
  
  
• Rheumatoid Arthritis: A Study of Ocrelizumab in Patients With Rheumatoid Arthritis Who Have an Inadequate Response to Methotrexate.
  Sainte-Foy, QC; Research Site:
  
  
• Rheumatoid Arthritis: A Study of Ocrelizumab in Patients With Rheumatoid Arthritis Who Have an Inadequate Response to Methotrexate.
  Toronto, ON; Research Site:
  
  
• Rheumatoid Arthritis: A Study of Ocrelizumab in Patients With Rheumatoid Arthritis Who Have an Inadequate Response to Methotrexate.
  Trois-Rivieres, QC; Research Site:
  
  
• Rheumatoid Arthritis: A Study of Ocrelizumab in Patients With Rheumatoid Arthritis Who Have an Inadequate Response to Methotrexate.
  Vancouver, BC; Research Site:
  
  
• Rheumatoid Arthritis: A Study of Ocrelizumab in Patients With Rheumatoid Arthritis Who Have an Inadequate Response to Methotrexate.
  Victoria, BC; Research Site:
  
  
• Rheumatoid Arthritis: A Study of Ocrelizumab in Patients With Rheumatoid Arthritis.
  Calgary, AB; Research Site:
  
  
• Rheumatoid Arthritis: A Study of Ocrelizumab in Patients With Rheumatoid Arthritis.
  Edmonton, AB; Research Site:
  
  
• Rheumatoid Arthritis: A Study of Ocrelizumab in Patients With Rheumatoid Arthritis.
  London, ON; Research Site:
  
  
• Rheumatoid Arthritis: A Study of Ocrelizumab in Patients With Rheumatoid Arthritis.
  Quebec City, QC; Research Site:
  
  
• Rheumatoid Arthritis: A Study of Ocrelizumab in Patients With Rheumatoid Arthritis.
  Sherbrooke, QC; Research Site:
  
  
• Rheumatoid Arthritis: A Study of Ocrelizumab in Patients With Rheumatoid Arthritis.
  Toronto, ON; Research Site:
  
  
• Rheumatoid Arthritis: A Study of P38 Inhibitor (4) in Patients With Active Rheumatoid Arthritis (RA) on Stable Methotrexate Therapy
  Edmonton, AB; Research Site:
  
  
• Rheumatoid Arthritis: A Study of P38 Inhibitor (4) in Patients With Active Rheumatoid Arthritis (RA) on Stable Methotrexate Therapy
  Mississauga, ON; Research Site:
  
  
• Rheumatoid Arthritis: A Study of P38 Inhibitor (4) in Patients With Active Rheumatoid Arthritis (RA) on Stable Methotrexate Therapy
  Ottawa, ON; Research Site:
  
  
• Rheumatoid Arthritis: A Study of P38 Inhibitor (4) in Patients With Active Rheumatoid Arthritis (RA) on Stable Methotrexate Therapy
  Pointe-Claire, QC; Research Site:
  
  
• Rheumatoid Arthritis: A Study of P38 Inhibitor (4) in Patients With Active Rheumatoid Arthritis (RA) on Stable Methotrexate Therapy
  Sainte-Foy, QC; Research Site:
  
  
• Rheumatoid Arthritis: A Study of P38 Inhibitor (4) in Patients With Active Rheumatoid Arthritis (RA) on Stable Methotrexate Therapy
  St John'S; Research Site:
  
  
• Rheumatoid Arthritis: A Study of P38 Inhibitor (4) in Patients With Active Rheumatoid Arthritis (RA) on Stable Methotrexate Therapy
  Toronto, ON; Research Site:
  
  
• Rheumatoid Arthritis: A Study of P38 Inhibitor (4) in Patients With Active Rheumatoid Arthritis (RA) on Stable Methotrexate Therapy
  Winnipeg, MB; Research Site:
  
  
• Rheumatoid Arthritis: A Study of P38 Inhibitor (4) Monotherapy in Patients With Active Rheumatoid Arthritis
  Edmonton, AB; Research Site:
  
  
• Rheumatoid Arthritis: A Study of P38 Inhibitor (4) Monotherapy in Patients With Active Rheumatoid Arthritis
  Halifax, NS; Research Site:
  
  
• Rheumatoid Arthritis: A Study of P38 Inhibitor (4) Monotherapy in Patients With Active Rheumatoid Arthritis
  Ottawa, ON; Research Site:
  
  
• Rheumatoid Arthritis: A Study of P38 Inhibitor (4) Monotherapy in Patients With Active Rheumatoid Arthritis
  Toronto, ON; Research Site:
  
  
• Rheumatoid Arthritis: A Study of Retreatment With MabThera (Rituximab) in Combination With Methotrexate in Patients With Rheumatoid Arthritis (RA)
  London, ON; Research Site:
  
  
• Rheumatoid Arthritis: A Study of Retreatment With MabThera (Rituximab) in Combination With Methotrexate in Patients With Rheumatoid Arthritis (RA)
  Newmarket, ON; Research Site:
  
  
• Rheumatoid Arthritis: A Study of Retreatment With MabThera (Rituximab) in Combination With Methotrexate in Patients With Rheumatoid Arthritis (RA)
  Penticton, BC; Research Site:
  
  
• Rheumatoid Arthritis: A Study of Retreatment With MabThera (Rituximab) in Combination With Methotrexate in Patients With Rheumatoid Arthritis (RA)
  Toronto, ON; Research Site:
  
  
• Rheumatoid Arthritis: A Study of Retreatment With MabThera (Rituximab) in Combination With Methotrexate in Patients With Rheumatoid Arthritis (RA)
  Trois-Rivieres, QC; Research Site:
  
  
• Rheumatoid Arthritis: A Study of Retreatment With MabThera (Rituximab) in Combination With Methotrexate in Patients With Rheumatoid Arthritis (RA)
  Victoria, BC; Research Site:
  
  
• Rheumatoid Arthritis: A Study of Retreatment With MabThera (Rituximab) in Combination With Methotrexate in Patients With Rheumatoid Arthritis (RA)
  Winnipeg, MB; Research Site:
  
  
• Rheumatoid Arthritis: A Study of the Effect of Tocilizumab on Markers of Atherogenic Risk in Patients With Moderate to Severe Rheumatoid Arthritis.
  Edmonton, AB; Research Site:
  
  
• Rheumatoid Arthritis: A Study of the Effect of Tocilizumab on Markers of Atherogenic Risk in Patients With Moderate to Severe Rheumatoid Arthritis.
  Hamilton, ON; Research Site:
  
  
• Rheumatoid Arthritis: A Study of the Effect of Tocilizumab on Markers of Atherogenic Risk in Patients With Moderate to Severe Rheumatoid Arthritis.
  Mississauga, ON; Research Site:
  
  
• Rheumatoid Arthritis: A Study of the Effect of Tocilizumab on Markers of Atherogenic Risk in Patients With Moderate to Severe Rheumatoid Arthritis.
  Ottawa, ON; Research Site:
  
  
• Rheumatoid Arthritis: A Study of the Effect of Tocilizumab on Markers of Atherogenic Risk in Patients With Moderate to Severe Rheumatoid Arthritis.
  Sainte-Foy, QC; Research Site:
  
  
• Rheumatoid Arthritis: A Study of the Effect of Tocilizumab on Markers of Atherogenic Risk in Patients With Moderate to Severe Rheumatoid Arthritis.
  St. John's, NL; Research Site:
  
  
• Rheumatoid Arthritis: A Study of the Effect of Tocilizumab on Markers of Atherogenic Risk in Patients With Moderate to Severe Rheumatoid Arthritis.
  Vancouver, BC; Research Site:
  
  
• Rheumatoid Arthritis: A Study of the Effect of Tocilizumab on Markers of Atherogenic Risk in Patients With Moderate to Severe Rheumatoid Arthritis.
  Winnipeg, MB; Research Site:
  
  
• Rheumatoid Arthritis: A Study of Tocilizumab in Patients Completing Treatment in WA17822
  Burlington, ON; Research Site:
  
  
• Rheumatoid Arthritis: A Study of Tocilizumab in Patients Completing Treatment in WA17822
  Calgary, AB; Research Site:
  
  
• Rheumatoid Arthritis: A Study of Tocilizumab in Patients Completing Treatment in WA17822
  Montreal, QC; Research Site:
  
  
• Rheumatoid Arthritis: A Study of Tocilizumab in Patients Completing Treatment in WA17822
  Newmarket, ON; Research Site:
  
  
• Rheumatoid Arthritis: A Study of Tocilizumab in Patients Completing Treatment in WA17822
  Ottawa, ON; Research Site:
  
  
• Rheumatoid Arthritis: A Study of Tocilizumab in Patients Completing Treatment in WA17822
  Sainte-Foy, QC; Research Site:
  
  
• Rheumatoid Arthritis: A Study of Tocilizumab in Patients Completing Treatment in WA17822
  St John'S; Research Site:
  
  
• Rheumatoid Arthritis: A Study of Tocilizumab in Patients Completing Treatment in WA17822
  Toronto, ON; Research Site:
  
  
• Rheumatoid Arthritis: A Study of Tocilizumab in Patients Completing Treatment in WA17822
  Victoria, BC; Research Site:
  
  
• Rheumatoid Arthritis: A Study of Tocilizumab in Patients Completing Treatment in WA17822
  Winnipeg, MB; Research Site:
  
  
• Rheumatoid Arthritis: A Study to Assess the Effect of Tocilizumab + DMARD Therapy on Signs and Symptoms in Patients With Moderate to Severe Active Rheumatoid Arthritis
  Hamilton, ON; Research Site:
  
  
• Rheumatoid Arthritis: A Study to Assess the Effect of Tocilizumab + DMARD Therapy on Signs and Symptoms in Patients With Moderate to Severe Active Rheumatoid Arthritis
  Ottawa, ON; Research Site:
  
  
• Rheumatoid Arthritis: A Study to Assess the Effect of Tocilizumab + DMARD Therapy on Signs and Symptoms in Patients With Moderate to Severe Active Rheumatoid Arthritis
  Quebec City, QC; Research Site:
  
  
• Rheumatoid Arthritis: A Study to Assess the Effect of Tocilizumab + DMARD Therapy on Signs and Symptoms in Patients With Moderate to Severe Active Rheumatoid Arthritis
  Saskatoon, SK; Research Site:
  
  
• Rheumatoid Arthritis: A Study to Assess the Effect of Tocilizumab + DMARD Therapy on Signs and Symptoms in Patients With Moderate to Severe Active Rheumatoid Arthritis
  Winnipeg, MB; Research Site:
  
  
• Rheumatoid Arthritis: A Study to Assess the Effect of Tocilizumab + Methotrexate on Signs and Symptoms in Patients With Moderate to Severe Active Rheumatoid Arthritis
  Burlington, ON; Research Site:
  
  
• Rheumatoid Arthritis: A Study to Assess the Effect of Tocilizumab + Methotrexate on Signs and Symptoms in Patients With Moderate to Severe Active Rheumatoid Arthritis
  Calgary, AB; Research Site:
  
  
• Rheumatoid Arthritis: A Study to Assess the Effect of Tocilizumab + Methotrexate on Signs and Symptoms in Patients With Moderate to Severe Active Rheumatoid Arthritis
  Montreal, QC; Research Site:
  
  
• Rheumatoid Arthritis: A Study to Assess the Effect of Tocilizumab + Methotrexate on Signs and Symptoms in Patients With Moderate to Severe Active Rheumatoid Arthritis
  Newmarket, ON; Research Site:
  
  
• Rheumatoid Arthritis: A Study to Assess the Effect of Tocilizumab + Methotrexate on Signs and Symptoms in Patients With Moderate to Severe Active Rheumatoid Arthritis
  Ottawa, ON; Research Site:
  
  
• Rheumatoid Arthritis: A Study to Assess the Effect of Tocilizumab + Methotrexate on Signs and Symptoms in Patients With Moderate to Severe Active Rheumatoid Arthritis
  Sainte-Foy, QC; Research Site:
  
  
• Rheumatoid Arthritis: A Study to Assess the Effect of Tocilizumab + Methotrexate on Signs and Symptoms in Patients With Moderate to Severe Active Rheumatoid Arthritis
  St John'S; Research Site:
  
  
• Rheumatoid Arthritis: A Study to Assess the Effect of Tocilizumab + Methotrexate on Signs and Symptoms in Patients With Moderate to Severe Active Rheumatoid Arthritis
  Toronto, ON; Research Site:
  
  
• Rheumatoid Arthritis: A Study to Assess the Effect of Tocilizumab + Methotrexate on Signs and Symptoms in Patients With Moderate to Severe Active Rheumatoid Arthritis
  Vancouver, BC; Research Site:
  
  
• Rheumatoid Arthritis: A Study to Assess the Effect of Tocilizumab + Methotrexate on Signs and Symptoms in Patients With Moderate to Severe Active Rheumatoid Arthritis
  Victoria, BC; Research Site:
  
  
• Rheumatoid Arthritis: A Study to Assess the Effect of Tocilizumab + Methotrexate on Signs and Symptoms in Patients With Moderate to Severe Active Rheumatoid Arthritis
  Winnipeg, MB; Research Site:
  
  
• Rheumatoid Arthritis: A Study to Assess the Effect of Tocilizumab + Methotrexate on Signs and Symptoms in Patients With Moderate to Severe Active Rheumatoid Arthritis Currently on Methotrexate Therapy
  Burlington, ON; Research Site:
  
  
• Rheumatoid Arthritis: A Study to Assess the Effect of Tocilizumab + Methotrexate on Signs and Symptoms in Patients With Moderate to Severe Active Rheumatoid Arthritis Currently on Methotrexate Therapy
  Calgary, AB; Research Site:
  
  
• Rheumatoid Arthritis: A Study to Assess the Effect of Tocilizumab + Methotrexate on Signs and Symptoms in Patients With Moderate to Severe Active Rheumatoid Arthritis Currently on Methotrexate Therapy
  Edmonton, AB; Research Site:
  
  
• Rheumatoid Arthritis: A Study to Assess the Effect of Tocilizumab + Methotrexate on Signs and Symptoms in Patients With Moderate to Severe Active Rheumatoid Arthritis Currently on Methotrexate Therapy
  Kitchener, ON; Research Site:
  
  
• Rheumatoid Arthritis: A Study to Assess the Effect of Tocilizumab + Methotrexate on Signs and Symptoms in Patients With Moderate to Severe Active Rheumatoid Arthritis Currently on Methotrexate Therapy
  London, ON; Research Site:
  
  
• Rheumatoid Arthritis: A Study to Assess the Effect of Tocilizumab + Methotrexate on Signs and Symptoms in Patients With Moderate to Severe Active Rheumatoid Arthritis Currently on Methotrexate Therapy
  Mississauga, ON; Research Site:
  
  
• Rheumatoid Arthritis: A Study to Assess the Effect of Tocilizumab + Methotrexate on Signs and Symptoms in Patients With Moderate to Severe Active Rheumatoid Arthritis Currently on Methotrexate Therapy
  Montreal, QC; Research Site:
  
  
• Rheumatoid Arthritis: A Study to Assess the Effect of Tocilizumab + Methotrexate on Signs and Symptoms in Patients With Moderate to Severe Active Rheumatoid Arthritis Currently on Methotrexate Therapy
  Newmarket, ON; Research Site:
  
  
• Rheumatoid Arthritis: A Study to Assess the Effect of Tocilizumab + Methotrexate on Signs and Symptoms in Patients With Moderate to Severe Active Rheumatoid Arthritis Currently on Methotrexate Therapy
  Sainte-Foy, QC; Research Site:
  
  
• Rheumatoid Arthritis: A Study to Assess the Effect of Tocilizumab + Methotrexate on Signs and Symptoms in Patients With Moderate to Severe Active Rheumatoid Arthritis Currently on Methotrexate Therapy
  Toronto, ON; Research Site:
  
  
• Rheumatoid Arthritis: A Study to Assess the Effect of Tocilizumab + Methotrexate on Signs and Symptoms in Patients With Moderate to Severe Active Rheumatoid Arthritis Currently on Methotrexate Therapy
  Winnipeg, MB; Research Site:
  
  
• Rheumatoid Arthritis: A Study to Assess the Efficacy and Safety of MabThera (Rituximab) in Patients With Rheumatoid Arthritis
  Calgary, AB; Research Site:
  
  
• Rheumatoid Arthritis: A Study to Assess the Efficacy and Safety of MabThera (Rituximab) in Patients With Rheumatoid Arthritis
  London, ON; Research Site:
  
  
• Rheumatoid Arthritis: A Study to Assess the Efficacy and Safety of MabThera (Rituximab) in Patients With Rheumatoid Arthritis
  St John'S; Research Site:
  
  
• Rheumatoid Arthritis: A Study to Assess the Efficacy and Safety of MabThera (Rituximab) in Patients With Rheumatoid Arthritis
  Vancouver, BC; Research Site:
  
  
• Rheumatoid Arthritis: A Study to Assess the Efficacy and Safety of Retreatment With MabThera (Rituximab) in Patients With Active Rheumatoid Arthritis (RA)
  Calgary, AB; Research Site:
  
  
• Rheumatoid Arthritis: A Study to Assess the Efficacy and Safety of Retreatment With MabThera (Rituximab) in Patients With Active Rheumatoid Arthritis (RA)
  St John'S; Research Site:
  
  
• Rheumatoid Arthritis: A Study to Assess the Efficacy and Safety of Retreatment With MabThera (Rituximab) in Patients With Active Rheumatoid Arthritis (RA)
  Vancouver, BC; Research Site:
  
  
• Rheumatoid Arthritis: A Study to Assess the Safety and Efficacy of Retreatment With MabThera (Rituximab) in Patients With Rheumatoid Arthritis Who Have Failed on anti-TNFalfa Therapy
  Calgary, AB; Research Site:
  
  
• Rheumatoid Arthritis: A Study to Assess the Safety and Efficacy of Retreatment With MabThera (Rituximab) in Patients With Rheumatoid Arthritis Who Have Failed on anti-TNFalfa Therapy
  Edmonton, AB; Research Site:
  
  
• Rheumatoid Arthritis: A Study to Assess the Safety and Efficacy of Retreatment With MabThera (Rituximab) in Patients With Rheumatoid Arthritis Who Have Failed on anti-TNFalfa Therapy
  Hamilton, ON; Research Site:
  
  
• Rheumatoid Arthritis: A Study to Assess the Safety and Efficacy of Retreatment With MabThera (Rituximab) in Patients With Rheumatoid Arthritis Who Have Failed on anti-TNFalfa Therapy
  London, ON; Research Site:
  
  
• Rheumatoid Arthritis: A Study to Assess the Safety and Efficacy of Retreatment With MabThera (Rituximab) in Patients With Rheumatoid Arthritis Who Have Failed on anti-TNFalfa Therapy
  Toronto, ON; Research Site:
  
  
• Rheumatoid Arthritis: A Study to Assess the Safety and Efficacy of Tocilizumab in Patients With Active Rheumatoid Arthritis
  Burlington, ON; Research Site:
  
  
• Rheumatoid Arthritis: A Study to Assess the Safety and Efficacy of Tocilizumab in Patients With Active Rheumatoid Arthritis
  Hamilton, ON; Research Site:
  
  
• Rheumatoid Arthritis: A Study to Assess the Safety and Efficacy of Tocilizumab in Patients With Active Rheumatoid Arthritis
  Kitchener, ON; Research Site:
  
  
• Rheumatoid Arthritis: A Study to Assess the Safety and Efficacy of Tocilizumab in Patients With Active Rheumatoid Arthritis
  Mississauga, ON; Research Site:
  
  
• Rheumatoid Arthritis: A Study to Assess the Safety and Efficacy of Tocilizumab in Patients With Active Rheumatoid Arthritis
  Ottawa, ON; Research Site:
  
  
• Rheumatoid Arthritis: A Study to Assess the Safety and Efficacy of Tocilizumab in Patients With Active Rheumatoid Arthritis
  Sainte-Foy, QC; Research Site:
  
  
• Rheumatoid Arthritis: A Study to Assess the Safety and Efficacy of Tocilizumab in Patients With Active Rheumatoid Arthritis
  St John'S; Research Site:
  
  
• Rheumatoid Arthritis: A Study to Assess the Safety and Efficacy of Tocilizumab in Patients With Active Rheumatoid Arthritis
  Victoria, BC; Research Site:
  
  
• Rheumatoid Arthritis: A Study to Assess the Safety and Efficacy of Tocilizumab in Patients With Active Rheumatoid Arthritis
  Winnipeg, MB; Research Site:
  
  
• Rheumatoid Arthritis: A Study to Evaluate the Safety and Efficacy of MabThera (Rituximab) in Patients With Rheumatoid Arthritis Who Have Failed on Anti-TNFalfa Therapy
  Calgary, AB; Research Site:
  
  
• Rheumatoid Arthritis: A Study to Evaluate the Safety and Efficacy of MabThera (Rituximab) in Patients With Rheumatoid Arthritis Who Have Failed on Anti-TNFalfa Therapy
  Edmonton, AB; Research Site:
  
  
• Rheumatoid Arthritis: A Study to Evaluate the Safety and Efficacy of MabThera (Rituximab) in Patients With Rheumatoid Arthritis Who Have Failed on Anti-TNFalfa Therapy
  Hamilton, ON; Research Site:
  
  
• Rheumatoid Arthritis: A Study to Evaluate the Safety and Efficacy of MabThera (Rituximab) in Patients With Rheumatoid Arthritis Who Have Failed on Anti-TNFalfa Therapy
  London, ON; Research Site:
  
  
• Rheumatoid Arthritis: A Study to Evaluate the Safety and Efficacy of MabThera (Rituximab) in Patients With Rheumatoid Arthritis Who Have Failed on Anti-TNFalfa Therapy
  Toronto, ON; Research Site:
  
  
• Rheumatoid Arthritis: A Study to Evaluate the Safety and Efficacy of MabThera (Rituximab) in Patients With Rheumatoid Arthritis Who Have Failed on Anti-TNFalfa Therapy
  Vancouver, BC; Research Site:
  
  
• Rheumatoid Arthritis: An Extension Study of Tocilizumab in Patients Completing Treatment in Tocilizumab Core Studies
  Burlington, ON; Research Site:
  
  
• Rheumatoid Arthritis: An Extension Study of Tocilizumab in Patients Completing Treatment in Tocilizumab Core Studies
  Calgary, AB; Research Site:
  
  
• Rheumatoid Arthritis: An Extension Study of Tocilizumab in Patients Completing Treatment in Tocilizumab Core Studies
  Edmonton, AB; Research Site:
  
  
• Rheumatoid Arthritis: An Extension Study of Tocilizumab in Patients Completing Treatment in Tocilizumab Core Studies
  Hamilton, ON; Research Site:
  
  
• Rheumatoid Arthritis: An Extension Study of Tocilizumab in Patients Completing Treatment in Tocilizumab Core Studies
  Kitchener, ON; Research Site:
  
  
• Rheumatoid Arthritis: An Extension Study of Tocilizumab in Patients Completing Treatment in Tocilizumab Core Studies
  London, ON; Research Site:
  
  
• Rheumatoid Arthritis: An Extension Study of Tocilizumab in Patients Completing Treatment in Tocilizumab Core Studies
  Mississauga, ON; Research Site:
  
  
• Rheumatoid Arthritis: An Extension Study of Tocilizumab in Patients Completing Treatment in Tocilizumab Core Studies
  Montreal, QC; Research Site:
  
  
• Rheumatoid Arthritis: An Extension Study of Tocilizumab in Patients Completing Treatment in Tocilizumab Core Studies
  Ottawa, ON; Research Site:
  
  
• Rheumatoid Arthritis: An Extension Study of Tocilizumab in Patients Completing Treatment in Tocilizumab Core Studies
  Quebec City, QC; Research Site:
  
  
• Rheumatoid Arthritis: An Extension Study of Tocilizumab in Patients Completing Treatment in Tocilizumab Core Studies
  Sainte-Foy, QC; Research Site:
  
  
• Rheumatoid Arthritis: An Extension Study of Tocilizumab in Patients Completing Treatment in Tocilizumab Core Studies
  Saskatoon, SK; Research Site:
  
  
• Rheumatoid Arthritis: An Extension Study of Tocilizumab in Patients Completing Treatment in Tocilizumab Core Studies
  St John'S; Research Site:
  
  
• Rheumatoid Arthritis: An Extension Study of Tocilizumab in Patients Completing Treatment in Tocilizumab Core Studies
  Toronto, ON; Research Site:
  
  
• Rheumatoid Arthritis: An Extension Study of Tocilizumab in Patients Completing Treatment in Tocilizumab Core Studies
  Victoria, BC; Research Site:
  
  
• Rheumatoid Arthritis: An Extension Study of Tocilizumab in Patients Completing Treatment in Tocilizumab Core Studies
  Winnipeg, MB; Research Site:
  
  
• Rheumatoid Arthritis: Dosing Flexibility Study in Patients With RA
  Burlington, Ontario; UCB Clinical Trial Call Center
  
  
• Rheumatoid Arthritis: Dosing Flexibility Study in Patients With RA
  Saskatoon, Saskatchewan; UCB Clinical Trial Call Center
  
  
• Rheumatoid Arthritis: Dosing Flexibility Study in Patients With RA
  St John's, NL; UCB Clinical Trial Call Center
  
  
• Rheumatoid Arthritis: Dosing Flexibility Study in Patients With RA
  Toronto, Ontario; UCB Clinical Trial Call Center
  
  
• Rheumatoid Arthritis: Dosing Flexibility Study in Patients With RA
  Toronto, Ontario; UCB Clinical Trial Call Center
  
  
• Rheumatoid Arthritis: SCORE Study: A Study of MabThera (Rituximab) in Patients With Rheumatoid Arthritis and Inadequate Response to Methotrexate.
  Montreal, QC; Research Site:
  
  
• Rheumatoid Arthritis: SCORE Study: A Study of MabThera (Rituximab) in Patients With Rheumatoid Arthritis and Inadequate Response to Methotrexate.
  Ottawa, ON; Research Site:
  
  
• Rheumatoid Arthritis: SCORE Study: A Study of MabThera (Rituximab) in Patients With Rheumatoid Arthritis and Inadequate Response to Methotrexate.
  Quebec City, QC; Research Site:
  
  
• Rheumatoid Arthritis: SCORE Study: A Study of MabThera (Rituximab) in Patients With Rheumatoid Arthritis and Inadequate Response to Methotrexate.
  Saskatoon, SK; Research Site:
  
  
• Rheumatoid Arthritis: SCORE Study: A Study of MabThera (Rituximab) in Patients With Rheumatoid Arthritis and Inadequate Response to Methotrexate.
  St John'S; Research Site:
  
  
• Rheumatoid Arthritis: SCORE Study: A Study of MabThera (Rituximab) in Patients With Rheumatoid Arthritis and Inadequate Response to Methotrexate.
  Toronto, ON; Research Site:
  
  
• Rheumatoid Arthritis: SCORE Study: A Study of MabThera (Rituximab) in Patients With Rheumatoid Arthritis and Inadequate Response to Methotrexate.
  Winnipeg, MB; Research Site:
  
  
• Systemic Lupus Erythematosus: A Study of Ocrelizumab in Patients With Nephritis Due to Systemic Lupus Erythematosus.
  Scarborough, ON; Research Site:
  
  
• Systemic Lupus Erythematosus: A Study of Ocrelizumab in Patients With Nephritis Due to Systemic Lupus Erythematosus.
  Toronto, ON; Research Site:
  
  
• Systemic Lupus Erythematosus: A Study of Ocrelizumab in Patients With Systemic Lupus Erythematosus.
  Kitchener, QC; Research Site:
  
  
• Systemic Lupus Erythematosus: A Study of Ocrelizumab in Patients With Systemic Lupus Erythematosus.
  London, ON; Research Site:
  
  
• Systemic Lupus Erythematosus: A Study of Ocrelizumab in Patients With Systemic Lupus Erythematosus.
  Sherbrooke, QC; Research Site:
  
  
• Systemic Lupus Erythematosus: A Study of Ocrelizumab in Patients With Systemic Lupus Erythematosus.
  Toronto, ON; Research Site:
  
  
• Systemic Lupus Erythematosus: A Study of Ocrelizumab in Patients With Systemic Lupus Erythematosus.
  Vancouver, BC; Research Site:
  
  

Chile

• Post-Menopausal Osteoporosis: A Study of Adherence to Bonviva (Ibandronate) Once Monthly in Women With Post-Menopausal Osteoporosis.
  Santiago; Research Site:
  
  
• Post-Menopausal Osteoporosis: A Study of Adherence to Bonviva (Ibandronate) Once Monthly in Women With Post-Menopausal Osteoporosis.
  Vina Del Mar; Research Site:
  
  
• Rheumatoid Arthritis: A Non-Comparative Study to Assess the Safety of MabThera (Rituximab) in Patients With Rheumatoid Arthritis.
  Santiago; Research Site:
  
  
• Systemic Lupus Erythematosus: A Study of Ocrelizumab in Patients With Nephritis Due to Systemic Lupus Erythematosus.
  Concepcion; Research Site:
  
  
• Systemic Lupus Erythematosus: A Study of Ocrelizumab in Patients With Nephritis Due to Systemic Lupus Erythematosus.
  Puente Alto; Research Site:
  
  
• Systemic Lupus Erythematosus: A Study of Ocrelizumab in Patients With Nephritis Due to Systemic Lupus Erythematosus.
  Santiago; Research Site:
  
  
• Systemic Lupus Erythematosus: A Study of Ocrelizumab in Patients With Systemic Lupus Erythematosus.
  Concepcion; Research Site:
  
  
• Systemic Lupus Erythematosus: A Study of Ocrelizumab in Patients With Systemic Lupus Erythematosus.
  Puente Alto; Research Site:
  
  
• Systemic Lupus Erythematosus: A Study of Ocrelizumab in Patients With Systemic Lupus Erythematosus.
  Santiago; Research Site:
  
  

China

• Lupus: A Study of CellCept (Mycophenolate Mofetil) in Management of Patients With Lupus Nephritis.
  Beijing; Research Site:
  
  
• Lupus: A Study of CellCept (Mycophenolate Mofetil) in Management of Patients With Lupus Nephritis.
  Guangzhou; Research Site:
  
  
• Lupus: A Study of CellCept (Mycophenolate Mofetil) in Management of Patients With Lupus Nephritis.
  Nanjing; Research Site:
  
  
• Lupus: A Study of CellCept (Mycophenolate Mofetil) in Management of Patients With Lupus Nephritis.
  Shanghai; Research Site:
  
  
• Lupus: A Study of CellCept (Mycophenolate Mofetil) in Patients With Lupus Nephritis.
  Beijing; Research Site:
  
  
• Lupus: A Study of CellCept (Mycophenolate Mofetil) in Patients With Lupus Nephritis.
  Guangzhou; Research Site:
  
  
• Lupus: A Study of CellCept (Mycophenolate Mofetil) in Patients With Lupus Nephritis.
  Hangzhou; Research Site:
  
  
• Lupus: A Study of CellCept (Mycophenolate Mofetil) in Patients With Lupus Nephritis.
  Nanjing; Research Site:
  
  
• Lupus: A Study of CellCept (Mycophenolate Mofetil) in Patients With Lupus Nephritis.
  Shanghai; Research Site:
  
  
• Post-Menopausal Osteoporosis: A Study Comparing Monthly Bonviva (Ibandronate) and Weekly Alendronate in Women With Post-Menopausal Osteoporosis.
  Beijing; Research Site:
  
  
• Post-Menopausal Osteoporosis: A Study Comparing Monthly Bonviva (Ibandronate) and Weekly Alendronate in Women With Post-Menopausal Osteoporosis.
  Changsha; Research Site:
  
  
• Post-Menopausal Osteoporosis: A Study Comparing Monthly Bonviva (Ibandronate) and Weekly Alendronate in Women With Post-Menopausal Osteoporosis.
  Guangzhou; Research Site:
  
  
• Post-Menopausal Osteoporosis: A Study Comparing Monthly Bonviva (Ibandronate) and Weekly Alendronate in Women With Post-Menopausal Osteoporosis.
  Hong Kong; Research Site:
  
  
• Post-Menopausal Osteoporosis: A Study Comparing Monthly Bonviva (Ibandronate) and Weekly Alendronate in Women With Post-Menopausal Osteoporosis.
  Nanjing; Research Site:
  
  
• Post-Menopausal Osteoporosis: A Study Comparing Monthly Bonviva (Ibandronate) and Weekly Alendronate in Women With Post-Menopausal Osteoporosis.
  Shanghai; Research Site:
  
  
• Post-Menopausal Osteoporosis: BonAdAsia study--A Study of Once Monthly Bonviva (Ibandronate)in Women With Post-Menopausal Osteoporosis
  Hong Kong; Research Site:
  
  
• Post-Menopausal Osteoporosis: ExBonAdAsia Study: A Study of Once Monthly Bonviva (Ibandronate) in Women With Post-Menopausal Osteoporosis.
  Hong Kong; Research Site:
  
  
• Rheumatoid Arthritis: A Study of MabThera (Rituximab) in Combination With Methotrexate in Methotrexate-Naive Patients With Rheumatoid Arthritis (RA)
  Beijing; Research Site:
  
  
• Rheumatoid Arthritis: A Study of MabThera (Rituximab) in Combination With Methotrexate in Methotrexate-Naive Patients With Rheumatoid Arthritis (RA)
  Shanghai; Research Site:
  
  
• Rheumatoid Arthritis: A Study of Ocrelizumab in Combination With Methotrexate in Patients With Rheumatoid Arthritis Who Are Naive to Methotrexate
  Beijing; Research Site:
  
  
• Rheumatoid Arthritis: A Study of Ocrelizumab in Combination With Methotrexate in Patients With Rheumatoid Arthritis Who Are Naive to Methotrexate
  Jinan; Research Site:
  
  
• Rheumatoid Arthritis: A Study of Ocrelizumab in Patients With Rheumatoid Arthritis Who Have an Inadequate Response to Methotrexate.
  Chai Wan; Research Site:
  
  
• Rheumatoid Arthritis: A Study of Ocrelizumab in Patients With Rheumatoid Arthritis Who Have an Inadequate Response to Methotrexate.
  Hong Kong; Research Site:
  
  
• Rheumatoid Arthritis: A Study of Retreatment With MabThera (Rituximab) in Combination With Methotrexate in Patients With Rheumatoid Arthritis (RA)
  Beijing; Research Site:
  
  
• Rheumatoid Arthritis: A Study of Tocilizumab in Patients Completing Treatment in WA17822
  Hong Kong; Research Site:
  
  
• Rheumatoid Arthritis: A Study of Tocilizumab in Patients Completing Treatment in WA17822
  Tuen Mun; Research Site:
  
  
• Rheumatoid Arthritis: A Study to Assess the Effect of Tocilizumab + DMARD Therapy on Signs and Symptoms in Patients With Moderate to Severe Active Rheumatoi